Tuesday, November 30, 2010

Health - Senate Passes Overhaul of Food Safety Regulations

Health - Senate Passes Overhaul of Food Safety Regulations


Senate Passes Overhaul of Food Safety Regulations

Posted: 30 Nov 2010 11:12 AM PST

WASHINGTON — The Senate on Tuesday passed a sweeping overhaul of the nation’s food-safety system, after recalls of tainted eggs, peanut butter and spinach that sickened thousands and led major food makers to join consumer advocates in demanding stronger government oversight.

The legislation, which passed by a vote of 73 to 25, would greatly strengthen the Food and Drug Administration, an agency that in recent decades focused more on policing medical products than ensuring the safety of foods. The bill is intended to get the government to crack down on unsafe foods before they harm people rather than after outbreaks occur.

Despite unusual bipartisan support on Capitol Hill and a strong push from the Obama administration, the bill could still die because there might not be enough time for the usual haggling between the Senate and House of Representatives, which passed its own version last year. Top House Democrats said that they would consider simply passing the Senate version to speed approval.

Both versions of the bill would grant the F.D.A. new powers to recall tainted foods, increase inspections, demand accountability from food companies and oversee farming. But neither version would consolidate overlapping functions at the Department of Agriculture and nearly a dozen other federal agencies that oversee various aspects of food safety, making coordination among the agencies a continuing challenge.

While food-safety advocates and many industry groups preferred the House version because it includes more money for inspections and fewer exceptions from the rules it sets out, most said the Senate bill was far better than nothing.

“This is an historic moment,” said Erik Olson, deputy director of the Pew Health Group, an advocacy group. “For the first time in over 70 years, the Senate has approved an overhaul of F.D.A.’s food safety law that will help ensure that the food we put on our kitchen tables will be safer.”

Among the Senate bill’s last major sticking points was how it would affect small farmers and food producers. Some small-farm and organic food advocates warned that the legislation would destroy their industry under a mountain of paperwork, and Senator Jon Tester, a Democrat of Montana, pushed for a recent addition to the bill that exempts producers with less than $500,000 a year in sales who sell most of their food locally.

That provision led the United Fresh Produce Association, a trade group, to announce recently that it would oppose the legislation since small food operations have been the source of some food recalls in recent years.

But Randy Napier of Medina, Ohio, said the Senate bill was better than nothing. Mr. Napier’s 80-year-old mother, Nellie Napier, died in January 2009 after the nursing home in which she lived continued to feed her contaminated peanut butter even after she got sick.

“I am appalled at what I have found out since my mother’s death about how poorly food is regulated and how these companies cut corners to save money,” Mr. Napier said.

The staunch opposition of Senator Tom Coburn, an Oklahoma Republican, forced months of delay and eventually required Senate Majority Leader Harry Reid of Nevada to call a series of time-consuming procedural votes to end debate. Mr. Coburn offered his own version of the legislation eliminating many of its requirements because he said less regulation was needed, not more, but that version failed.

Despite Mr. Coburn’s opposition, the bill is one of the only major pieces of bipartisan legislation to emerge from this Congress. Some Republican and Democratic Senate staff members — who in previous terms would have seen each other routinely — met for the first time during the food negotiations. The group bonded over snacks: specifically, Starburst candies from a staff member of Senator Mike Enzi, a Wyoming Republican, and jelly beans from a staff member of Senator Richard J. Durbin, an Illinois Democrat. And in the midst of negotiations, the negotiators — nearly all women — took a field trip to a nearby food market so that a Republican staff member could teach the Democrats how to buy high-quality steaks.

“This legislation means that parents who tell their kids to eat their spinach can be assured that it won’t make them sick,” said Senator Tom Harkin, a Democrat from Iowa who, as chairman of the Senate health committee, shepherded the legislation through months of negotiations.

Health advocates are hoping the legislation will rekindle the progress — now stalled — that the nation once enjoyed in reducing the tens of millions of food contamination illnesses that occur each year. In the case of toxic salmonella, infections may be creeping upward.

Part of the problem is the growing industrialization and globalization of the nation’s food supply. Nearly a fifth of the nation’s food supply and as much as three-quarters of its seafood are imported, but the F.D.A. inspects less than one pound in a million of such imported foods. The bill gives the F.D.A. more control over food imports, including increased inspection of foreign processing plants and the ability to set standards for how fruits and vegetables are grown abroad.

And as food suppliers grow in size, problems at one facility can sicken thousands all over the country. The Peanut Corporation of America’s contaminated paste was included in scores of cookies and snacks made by big and small companies. The legislation would raise standards at such plants by demanding that food companies write plans to manufacture foods safely and conduct routine tests to ensure that the plans are adequate.

Report Questions Need for 2 Diet Supplements

Posted: 30 Nov 2010 08:25 AM PST

The very high levels of vitamin D that are often recommended by doctors and testing laboratories — and can be achieved only by taking supplements — are unnecessary and could be harmful, an expert committee says. It also concludes that calcium supplements are not needed.

Lawrence Lool/European Pressphoto Agency

A vitamin D pill.

The group said most people have adequate amounts of vitamin D in their blood supplied by their diets and natural sources like sunshine, the committee says in a report that is to be released on Tuesday.

“For most people, taking extra calcium and vitamin D supplements is not indicated,” said Dr. Clifford J. Rosen, a member of the panel and an osteoporosis expert at the Maine Medical Center Research Institute.

Dr. J. Christopher Gallagher, director of the bone metabolism unit at the Creighton University School of Medicine in Omaha, Neb., agreed, adding, “The onus is on the people who propose extra calcium and vitamin D to show it is safe before they push it on people.”

Over the past few years, the idea that nearly everyone needs extra calcium and vitamin D — especially vitamin D — has swept the nation.

With calcium, adolescent girls may be the only group that is getting too little, the panel found. Older women, on the other hand, may take too much, putting themselves at risk for kidney stones. And there is evidence that excess calcium can increase the risk of heart disease, the group wrote.

As for vitamin D, some prominent doctors have said that most people need supplements or they will be at increased risk for a wide variety of illnesses, including heart disease, cancer and autoimmune diseases.

And these days more and more people know their vitamin D levels because they are being tested for it as part of routine physical exams.

“The number of vitamin D tests has exploded,” said Dennis Black, a reviewer of the report who is a professor of epidemiology and biostatistics at the University of California, San Francisco.

At the same time, vitamin D sales have soared, growing faster than those of any supplement, according to The Nutrition Business Journal. Sales rose 82 percent from 2008 to 2009, reaching $430 million. “Everyone was hoping vitamin D would be kind of a panacea,” Dr. Black said. The report, he added, might quell the craze.

“I think this will have an impact on a lot of primary care providers,” he said.

The 14-member expert committee was convened by the Institute of Medicine, an independent nonprofit scientific body, at the request of the United States and Canadian governments. It was asked to examine the available data — nearly 1,000 publications — to determine how much vitamin D and calcium people were getting, how much was needed for optimal health and how much was too much.

The two nutrients work together for bone health.

Bone health, though, is only one of the benefits that have been attributed to vitamin D, and there is not enough good evidence to support most other claims, the committee said.

Some labs have started reporting levels of less than 30 nanograms of vitamin D per milliliter of blood as a deficiency. With that as a standard, 80 percent of the population would be deemed deficient of vitamin D, Dr. Rosen said. Most people need to take supplements to reach levels above 30 nanograms per milliliter, he added.

But, the committee concluded, a level of 20 to 30 nanograms is all that is needed for bone health, and nearly everyone is in that range.

Vitamin D is being added to more and more foods, said Paul R. Thomas of the Office of Dietary Supplements at the National Institutes of Health. Not only is it in orange juice and milk, but more is being added to breakfast cereals, and it now can be found in very high doses in supplement pills. Most vitamin D pills, he said, used to contain no more than 1,000 international units of it. Now it is easy to find pills, even in places like Wal-Mart, with 5,000 international units. The committee, though, said people need only 600 international units a day.

To assess the amounts of vitamin D and calcium people are getting, the panel looked at national data on diets. Most people, they concluded, get enough calcium from the foods they eat, about 1,000 milligrams a day for most adults (1,200 for women ages 51 to 70).

Vitamin D is more complicated, the group said. In general, most people are not getting enough vitamin D from their diets, but they have enough of the vitamin in their blood, probably because they are also making it naturally after being out in the sun and storing it in their bodies.

The American Society for Bone and Mineral Research and other groups applauded the report. It is “a very balanced set of recommendations,” said Dr. Sundeep Khosla, a Mayo Clinic endocrinologist and the society’s president.

But Andrew Shao, an executive vice president at the Council for Responsible Nutrition, a trade group, said the panel was being overly cautious, especially in its recommendations about vitamin D. He said there was no convincing evidence that people were being harmed by taking supplements, and he said higher levels of vitamin D, in particular, could be beneficial.

Such claims “are not supported by the available evidence,” the committee wrote. They were based on studies that observed populations and concluded that people with lower levels of the vitamin had more of various diseases. Such studies have been misleading and most scientists agree that they cannot determine cause and effect.

It is not clear how or why the claims for high vitamin D levels started, medical experts say. First there were two studies, which turned out to be incorrect, that said people needed 30 nanograms of vitamin D per milliliter of blood, the upper end of what the committee says is a normal range. They were followed by articles and claims and books saying much higher levels — 40 to 50 nanograms or even higher — were needed.

After reviewing the data, the committee concluded that the evidence for the benefits of high levels of vitamin D was “inconsistent and/or conflicting and did not demonstrate causality.”

Evidence also suggests that high levels of vitamin D can increase the risks for fractures and the overall death rate and can raise the risk for other diseases. While those studies are not conclusive, any risk looms large when there is no demonstrable benefit. Those hints of risk are “challenging the concept that ‘more is better,’ ” the committee wrote.

That is what surprised Dr. Black. “We thought that probably higher is better,” he said.

He has changed his mind, and expects others will too: “I think this report will make people more cautious.”

A Conversation With Julian L. Seifter: A Nephrologist and Patient

Posted: 30 Nov 2010 12:45 AM PST

Dr. Julian L. Seifter, 61, a nephrologist at Brigham and Women’s Hospital in Boston and a Harvard Medical School professor, specializes in treating patients who have chronic kidney disease.

We spoke at his Harvard office for three hours about his new book, “After the Diagnosis: Transcending Chronic Illness,” which was written with his wife, Betsy Seifter. It’s about living with diabetes, heart disease, lupus, even AIDS. An edited version of that conversation and subsequent e-mails follows.

Q. You are a doctor who treats people with chronic diseases. But you have one — diabetes. Are you a good patient?

A. Mixed. When I was diagnosed — 30 years ago — my first response was to run away from the illness. I was just at the beginning of my career, I had a young family and I didn’t want to be held back by my metabolic problems. Yes, I took insulin. But staying on a restrictive diet and monitoring my blood sugar levels was harder. I pretended to myself and others that I wasn’t sick.

I’ve had complications associated with three decades of diabetes — an eye hemorrhage, neuropathies. Over time I’ve tried for better control of my blood sugar levels, but I’ve never been perfectly successful. Good control means trying to duplicate what the pancreas does, and I never really wanted to become my pancreas.

Q. Has being a patient helped you be a doctor?

A. I’ve certainly learned things I’ve brought back to the clinic. I have a retinopathy, for instance, which can be a complication of diabetes. I don’t have good vision in my right eye, as a result. When this first happened, I said to my ophthalmologist, “I can’t lose vision. I need to read.” And he said, “Any vision is better than no vision.”

That was important. I started thinking, “Concentrate on things you still can do and develop some new things.” I’ve since started gardening, which doesn’t require the most acute vision. It’s something I probably wouldn’t have done otherwise. I counsel my patients to replace what they’ve lost with something new.

Q. Can you give an example?

A. I had one patient who was a scuba diver and who loved discovery. I had to tell him that with his condition scuba diving isn’t safe for him. So I’ve encouraged him to prospect for Native American relics in the Southwest desert, which he’s also interested in. It’s a way he can still be an explorer, but not risk his kidney.

Q. You write that a chronic disease can provide an opportunity for growth and personal development. That’s hard to imagine.

A. It can shake you out of old habits and routines. It takes away the “taken for granted.” You’re invited, almost forced, to find new directions and pursue unexplored potentials.

I had a patient, Cassandra, an opera singer, who first came to me because it was thought she had a kidney problem. It turned out she had a severe inflammatory condition in the head and neck — in the larynx, her instrument. She could no longer sing professionally. With no science background, she began reading the papers on her treatment and cultivated an interest in the illness. Eventually, she went back to college, took science courses and got accepted to medical school. She’s about to become a nephrologist.

Q. So a chronic disease diagnosis doesn’t have to be seen as The End?

A. It doesn’t have to be. Sometimes it is, though. I had another patient, a policeman, very overweight, with diabetes. He could drink a case of beer at a time. And he totally enjoyed his social life. By the time he was 60, he needed amputation and dialysis. He said, “I don’t want that.” I wasn’t going to talk him out of it. He had hospice care and he died peacefully.

If someone rejects dialysis, I want to make sure they’re not doing that because of depression. If a patient is wavering, I’ll say: “At least try it. You can always come off.” I had a patient who, at first, rejected dialysis, but who agreed to a trial and then found that the treatments made him feel so much better that he then wanted to stay on. It was a three-times-a-week commitment, but he came to see how he could fit it into his life — which he’d still have.

Q. Is it difficult to get patients to agree to a treatment as difficult as dialysis?

A. The alternative is death. I try to meet my patients wherever they are so that they will do it.

I had one who wanted to go to Florida a last time before starting dialysis. I worried about him. His condition was such that he might have heart failure. But I also knew he’d never go onto dialysis without doing this. I said, “O.K., call me when you land in Miami.” He said, “Doctor, you don’t understand, I’m driving down.”

Now, this was really dangerous. So I said, “Call me from each state and I’ll have the address of someone you can check in with in case there’s an emergency.”

The phone calls came in regularly until the last day of his trip. I was worried and I called his home in South Florida, and there was such an incredible noise in the background that I could hardly hear his wife. “What’s going on?” I asked. “That’s the rescue helicopter on the front lawn,” she said. He’d made it there, but then needed to be airlifted to the hospital!

Q. Do you regret enabling this journey?

A. No. From my own experiences, I understood why patients sometimes resist doing what’s best. The idea of sticking yourself with a needle every day for life: that wasn’t easy for me to accept. I hated the thought that every morning I was going to wake up knowing, “I have diabetes.” So I’m not a puritan with my patients. You have to do what is possible.

Q. In your book, you suggest a heretical idea: that chronic disease patients deny their situation, a little. You’d better explain.

A. They should do that, within reason. Everyone needs the opportunity to forget their disease for a while and think of other things. Otherwise, they can become their disease. So: I’m not a diabetic. I’m a doctor who has diabetes.

Of course, they should do everything that modern medicine offers. I always tell them that it is serious, but it’s not the end of all possibilities — you’re alive till you are dead. “It’s not over till it’s over.” Yogi Berra, he could have been a great clinician!

This posting includes an audio/video/photo media file: Download Now

An Odyssey Through the Brain

Posted: 30 Nov 2010 09:44 AM PST

Who has seen the mind? Neither you nor I — nor any of the legions of neuroscientists bent on opening the secrets of that invisible force, as powerful and erratic as the wind.

FROM PRIMITIVE TO NEON It is only fitting that the story of the brain should be a visual one, for the visuals had the ancients fooled for millenniums. The brain was so irredeemably ugly that they assumed the mind must lie elsewhere. Today those same skeletal silhouettes grow plump and brightly colored, courtesy of a variety of inserted genes encoding fluorescent molecules. More Photos »

The experts are definitely getting closer: the last few decades have produced an explosion of new techniques for probing the blobby, unprepossessing brain in search of the thinking, feeling, suffering, scheming mind.

But the field remains technologically complicated, out of reach for the average nonscientist, and still defined by research so basic that the human connection, the usual “hook” by which abstruse science captures general interest, is often missing.

Carl Schoonover took this all as a challenge. Mr. Schoonover, 27, is midway through a Ph.D. program in neuroscience at Columbia, and thought he would try to find a different hook. He decided to draw the general reader into his subject with the sheer beauty of its images.

So he has compiled them into a glossy new art book. “Portraits of the Mind: Visualizing the Brain From Antiquity to the 21st Century,” newly published by Abrams, includes short essays by prominent neuroscientists and long captions by Mr. Schoonover — but its words take second place to the gorgeous imagery, from the first delicate depictions of neurons sketched in prim Victorian black and white to the giant Technicolor splashes the same structures make across 21st-century LED screens.

Scientists are routinely seduced by beauty. Mr. Schoonover knows this firsthand, as he acknowledged in an interview: for a while his wallet held snapshots not of friends or family, but of particularly attractive neurons. Sometimes the aesthetics of the image itself captivate. Sometimes the thrill is the magic of a dead-on fabulous technique for getting at elusive data.

Consider, for instance, a blurry little black-and-white photograph of a smiley-face icon, so fuzzy and ill-defined it looks like a parody of the Shroud of Turin. The picture is actually a miracle in its own right: the high-speed video camera that shot it was trained on the exposed brain of a monkey staring at a yellow smiley face. As the monkey looked at the face, blood vessels supplying nerve cells in the visual part of the monkey’s brain transiently swelled in exactly the same pattern. We can tell what was on the monkey’s mind by inspecting its brain. The picture forms a link, primitive but palpable, between corporeal and evanescent, between the body and the spirit. And behind the photo stretches a long history of inspired neuroscientific deductions and equally inspired mistakes, all aiming to illuminate just that link.

It’s only fitting that the story should be a visual one, for the visuals had the ancients fooled for millenniums. The brain was so irredeemably ugly that they assumed the mind was elsewhere.

Aristotle, for example, concluded that the brain’s moist coils served only to cool the heart, the obvious home of the rational soul. The anatomist Galen pointed out that all nerves led to the brain, but medieval philosophers figured that most of the important things happened within the elegantly curved fluid-filled ventricles deep inside.

Only when the long ban on dissection petered out in the Renaissance did the ventricles prove to be so much empty space — poke the brain around a little, and they collapse and disappear. The gelatinous brain moved into the spotlight, as resistant to study as a giant mass of tightly packed cold spaghetti.

The challenge was twofold: what did that neural pasta really look like, and how did it do what it did?

In 1873 the Italian scientist Camillo Golgi developed a black stain to highlight the micron-thin neural strands. Fifteen years later the Spanish scientist Santiago Ramón y Cajal, deploying the stain with virtuoso dexterity, presented the world for the first time with visible populations of individual neurons, looking for all the world like burnt scrub brush in a postapocalyptic Dalí landscape. The roots, or dendrites, of these elongated nerve cells gather information. The trunks, or axons, transmit it.

This posting includes an audio/video/photo media file: Download Now

Drug Maker Wrote Book Under 2 Doctors’ Names, Documents Say

Posted: 30 Nov 2010 09:58 AM PST

Two prominent authors of a 1999 book teaching family doctors how to treat psychiatric disorders provided acknowledgment in the preface for an “unrestricted educational grant” from a major pharmaceutical company.

From the book “Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care.”

But the drug maker, then known as SmithKline Beecham, actually had much more involvement than the book described, newly disclosed documents show. The grant paid for a writing company to develop the outline and text for the two named authors, the documents show, and then the writing company said it planned to show three drafts directly to the pharmaceutical company for comments and “sign-off” and page proofs for “final approval.”

“That doesn’t sound unrestricted to me,” Dr. Bernard Lo, a medical ethicist and chairman of an Institute of Medicine group that wrote a 2009 report on conflicts of interest, said after reviewing the documents. “That sounds like they have ultimate control.”

The 269-page book, “Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care,” is so far the first book among publications, namely medical journal articles, that have been criticized in recent years for hidden drug industry influence, colloquially known as ghostwriting.

“To ghostwrite an entire textbook is a new level of chutzpah,” said Dr. David A. Kessler, former commissioner of the Food and Drug Administration, after reviewing the documents. “I’ve never heard of that before. It takes your breath away.”

The book has never been in wide circulation and has not been sold for a few years. Guidelines restricting the use of industry money to support medical journal articles or doctors’ research have come into wide acceptance within the last several years, to try to minimize the influence of companies’ marketing on medical practices.

The book’s listed co-authors were Dr. Charles B. Nemeroff, chairman of psychiatry at the University of Miami medical school since 2009 and Emory University before that, and Dr. Alan F. Schatzberg, who was chairman of psychiatry at the Stanford University School of Medicine from 1991 until last year.

The letter documenting the relationship between Dr. Nemeroff, a writing company and SmithKline was dated Feb. 4, 1997. It and a “preliminary draft” of the book, dated Feb. 21, 1997, and adding Dr. Schatzberg’s name were released Monday by the Project on Government Oversight, a Washington advocacy group. They were attached to a letter of complaint to Dr. Francis S. Collins, director of the National Institutes of Health. In the letter, Danielle Brian, executive director of the project, and Paul Thacker, an investigator, formerly with the staff of Senator Charles Grassley of Iowa, also cited other examples of what they termed ghostwriting and asked the N.I.H. for better policing of such practices.

The documents were separately obtained by The New York Times from the Los Angeles law firm of Baum Hedlund, which received them as part of discovery in lawsuits against the drug company, now known as GlaxoSmithKline, involving Paxil. Leemon B. McHenry, a bioethicist with California State University, Northridge, who consults for the law firm, said many similar documents remain sealed. “This is only the tip of the iceberg,” he said.

Responding to questions by e-mail last week, Dr. Nemeroff and Dr. Schatzberg emphasized the “unrestricted” nature of the grant from the drug maker to develop the book and said they did most of the work. SmithKline “had no involvement in content,” Dr. Schatzberg said, adding, “An unrestricted grant does not give the company any right of sign-off on content and in fact they had no sign-off in content.”

Dr. Nemeroff said he and Dr. Schatzberg “conceptualized this book, wrote the original outline and worked on all of the content.”

But the writing company, Scientific Therapeutics Information of Springfield, N.J., had developed “a complete content outline” for Dr. Nemeroff’s comment, according to the 1997 letter from one of the company’s officials. The company also said it had “begun development of the text.” The writing company did not respond to requests for comment.

Kevin G. Colgan, a spokesman for GlaxoSmithKline, said the company’s role in the book was described in its preface. In recent years, he added, the company has tightened its internal guidelines for medical writers.

Ron McMillen, chief executive of American Psychiatric Publishing, which published the book, said he reviewed files on it Monday and found no evidence of influence by the writing company or GlaxoSmithKline. But Mr. McMillen also said he had been unaware of the plan outlined in the two-page letter to Dr. Nemeroff.

“This would show more involvement than we would accept,” he said after reviewing it.

The book sold about 26,000 copies, including 10,000 bought by SmithKline Beecham for American family doctors and 10,000 purchased by the Dutch pharmaceutical company Organon, Mr. McMillen said. The authors together received a 15 percent royalty of the $120,000 sales, or about $18,000, he said.

Since there are about 100,000 family physicians in the United States, the book reached only a small percentage of them and has probably declined in usage since 1999. Dr. Howard A. Brody, an author, blogger and professor of family medicine at the University of Texas Medical Branch at Galveston, speculated that family doctors may have had some resistance to a book from a psychiatric press.

Mr. McMillen said the book was co-published with the American Medical Association. He said it was distributed until a few years ago.

Dr. Nemeroff said the book was written to fill an unmet need in educating family doctors and primary care physicians on how to provide adequate treatment for people with mental illness. “Remarkably, the book remains quite accurate and relevant to clinical practice today,” he said.

Dr. Nemeroff said he and Dr. Schatzberg “scrutinized every page and rewrote and edited as we deemed necessary,” keeping control of the final draft.

Dr. Schatzberg said he had not seen the 1997 letter to Dr. Nemeroff. He termed it “a theoretical proposal that bears little, if any relationship to what actually happened.”

Dr. Lo, who is a professor of medicine and director of the medical ethics program at the University of California, San Francisco, said that medical textbooks and handbooks should make it clear — as peer-reviewed journals now do — whose idea it was, who wrote the first draft, and who edited. Dr. Lo and other experts said ghostwriting has receded in recent years with tougher journal standards.

Dr. Nemeroff and Dr. Schatzberg have been listed on other titles, including co-editors of the Textbook of Psychopharmacology, a book for psychiatrists and medical students, whose third edition appeared in 2003. In 2008, Emory University imposed a two-year ban on Dr. Nemeroff receiving N.I.H. grants after a Senate inquiry found that he had failed to disclose at least $1.2 million in industry financing over seven years from pharmaceutical companies, including GlaxoSmithKline.

This posting includes an audio/video/photo media file: Download Now

Recipes for Health: Turkey and Rice Casserole With Yogurt Topping

Posted: 30 Nov 2010 10:32 AM PST

This Middle Eastern dish can also include fried stale pita bread that you douse with chicken or turkey stock before topping with the casserole. In the days after Thanksgiving, I’m likely to have all of these ingredients on hand — but not pita, so here I’ve done without it.

Recipes for Health

Martha Rose Shulman presents food that is vibrant and light, full of nutrients but by no means ascetic, fun to cook and to eat.

1 teaspoon ground allspice

3/4 teaspoon ground cinnamon

1/4 teaspoon ground pepper

1 medium onion, chopped

2 tablespoons extra virgin olive oil

1 cup basmati rice, rinsed in several changes of water

2 1/2 cups chicken or turkey stock

Salt to taste

3 garlic cloves

2 cups shredded turkey

2 cups drained yogurt or thick Greek-style yogurt

2 tablespoons fresh lemon juice

1/4 cup crushed or finely chopped walnuts

1. Mix together the allspice, cinnamon and pepper, and divide into 2 equal portions (1 teaspoon each). Set aside.

2. Heat 1 tablespoon of the olive oil over medium heat in a heavy 2- or 3-quart saucepan. Add the onion and a pinch of salt. Cook, stirring, until tender, about five minutes. Add the rice and 1 teaspoon of the spice mixture, and stir until the grains begin to crackle. Add 2 cups chicken stock and salt to taste (1/2 to 3/4 teaspoon). Bring to a boil, reduce the heat and simmer 15 minutes until the liquid has been absorbed by the rice. Remove the lid, and place a kitchen towel over the pot, then return the lid. Allow to sit undisturbed for 10 minutes.

3. Heat the oven to 350 degrees. Oil a 2-quart baking dish. Heat the remaining tablespoon of oil over medium heat in a large, heavy skillet, and add the garlic. As soon as it begins to smell fragrant, in a few seconds, add the remaining spices and the turkey. Stir together for about a minute until the turkey is coated with the mixture. Remove from the heat. Season to taste with salt.

4. Spread the rice in the casserole in an even layer. Top with the turkey. Douse with the remaining stock.

5. Place the garlic in a mortar and pestle with a pinch of salt and purée. Stir into the yogurt along with the lemon juice. Spread over the turkey in an even layer, making sure to completely cover the turkey so that it doesn’t dry out in the oven. Sprinkle on the nuts. Place in the oven and bake 15 to 20 minutes, just until warmed through. Do not allow the yogurt to bubble. Serve hot or warm.

Yield: Serves six.

Advance preparation: You can make this through Step 4 a day before you warm and serve it.

Nutritional information per serving: 331 calories; 12 grams fat; 3 grams saturated fat; 40 milligrams cholesterol; 33 grams carbohydrates; 2 grams dietary fiber; 84 milligrams sodium (does not include salt added during preparation); 24 grams protein

Martha Rose Shulman is the author of "The Very Best of Recipes for Health."

Well: Beauty Discrimination During a Job Search

Posted: 30 Nov 2010 12:52 PM PST

The New Old Age: The Graying Work Force

Posted: 30 Nov 2010 09:02 AM PST

Prescriptions: Merck Appoints a New Chief Executive

Posted: 30 Nov 2010 11:28 AM PST

Letters: Sit. Fetch. Heal. (1 Letter)

Posted: 29 Nov 2010 09:21 PM PST

To the Editor:

“Beyond the Facade, Post-Traumatic Stress” (Patient Voices, Nov. 23) called attention to an important part of the healing process for mental health patients: emotional support animals.

At Community Access — a 36-year-old nonprofit group dedicated to restoring the lives of people recovering from mental illness, homelessness and institutional confinement — we operate a pet-adoption and pet-therapy program. What we have seen is nothing short of a transformation.

Often, having a pet gives people a reason to get out of bed; a relationship based on unconditional love; a way to meet friends; and new responsibilities that can help lead to recovery.

Carla Rabinowitz

New York

The writer is an organizer with Community Access.

Science Times welcomes letters from readers. Those submitted for publication must include the writer’s name, address and telephone number. E-mail should be sent to scitimes@nytimes.com. Send letters to Science Editor, The New York Times, 620 Eighth Avenue, New York, N.Y. 10018.

Letters: Regulating Marijuana Use (1 Letter)

Posted: 29 Nov 2010 09:25 PM PST

To the Editor:

Re “Young Marijuana Users Pay a Cognitive Price” (Vital Signs, Nov. 23): The experience in the Netherlands offers a useful lesson.

The Dutch government has not legalized cannabis, and large-scale distributors have been jailed. But because of its policy of “harm reduction,” small amounts of marijuana can be bought in designated coffee shops.

Therefore, when the cognitive deficits and brain damage (including “schizophrenia-like symptoms”) linked to marijuana became known via scientific papers, the government was in a position to reduce access and to offer early treatment for adolescent cannabis abuse.

Fiona McGregor

San Francisco

Science Times welcomes letters from readers. Those submitted for publication must include the writer’s name, address and telephone number. E-mail should be sent to scitimes@nytimes.com. Send letters to Science Editor, The New York Times, 620 Eighth Avenue, New York, N.Y. 10018.

Recipes for Health: Risotto With Turkey, Mushrooms and Peas

Posted: 30 Nov 2010 10:30 AM PST

Turkey makes an unexpected but welcome addition to this traditional risotto.

Recipes for Health

Martha Rose Shulman presents food that is vibrant and light, full of nutrients but by no means ascetic, fun to cook and to eat.

1 ounce dried porcini mushrooms (about 1 cup)

5 cups well-seasoned chicken or vegetable stock

2 tablespoons extra virgin olive oil

1/2 cup minced onion

1 1/2 cups arborio rice

1 to 2 garlic cloves (to taste), minced

Salt and freshly ground pepper to taste

1/2 cup dry white wine, such as pinot grigio or sauvignon blanc

1 1/2 cups diced turkey

1 cup thawed frozen peas or cooked fresh peas

2 tablespoons minced chives

1/4 to 1/2 cup freshly grated Parmesan cheese (1 to 2 ounces)

1. Place the mushrooms in a large Pyrex measuring cup, and pour in 2 cups boiling water. Allow to sit for 30 minutes. Line a strainer with cheesecloth, place it over a bowl and strain the mushrooms. Squeeze the mushrooms over the strainer then rinse several times to rid them of sand. Set aside. Combine the mushroom soaking liquid with the stock in a saucepan.

2. Bring the stock to a simmer over low heat, with a ladle nearby or in the pot. Make sure that the stock is well seasoned.

3. Heat the olive oil over medium heat in a wide, heavy nonstick skillet or a wide, heavy saucepan. Add the onion and a generous pinch of salt, and cook gently until the onion is just tender, about three minutes. Do not brown.

4. Stir in the rice, porcinis and garlic. Stir until the grains separate and begin to crackle. Add the wine, and stir until it is no longer visible in the pan. Begin adding the simmering stock a couple of ladlefuls (about 1/2 cup) at a time. The stock should just cover the rice and should be bubbling neither too slowly nor too quickly. Cook, stirring often, until it is just about absorbed. Add another ladleful or two of the stock, and continue to cook in this fashion, adding more stock and stirring when the rice is almost dry. You do not have to stir constantly, but stir often. After 15 minutes, stir in the turkey and the peas, and continue to add stock as instructed above. The risotto is done in 20 to 25 minutes, when the rice is just tender all the way through but still chewy. Taste now and adjust seasoning.

5. Add another ladleful or two of stock to the rice. Stir in the chives and Parmesan, and remove from the heat. The mixture should be creamy (add more stock if it isn’t). Serve right away in wide soup bowls or on plates, spreading the risotto in a thin layer rather than a mound.

Yield: Serves four to six.

Advance preparation: You can begin up to several hours before serving. Proceed with the recipe and cook halfway through Step 3 — that is, for about 15 minutes. The rice should still be hard when you remove it from the heat, and there should not be any liquid in the pan. Spread it in an even layer in the pan and keep it away from the heat until you resume cooking. If the pan is not wide enough for you to spread the rice in a thin layer, transfer it to a sheet pan. Fifteen minutes before serving, bring the remaining stock back to a simmer, and reheat the rice. Resume cooking as instructed.

Nutritional information per serving (four servings): 527 calories; 12 grams fat; 3 grams saturated fat; 44 milligrams cholesterol; 69 grams carbohydrates; 7 grams dietary fiber; 639 milligrams sodium (does not include salt added during preparation); 31 grams protein

Nutritional information per serving (six servings): 352 calories; 8 grams fat; 2 grams saturated fat; 30 milligrams cholesterol; 46 grams carbohydrates; 5 grams dietary fiber; 426 milligrams sodium (does not include salt added during preparation); 20 grams protein

Martha Rose Shulman is the author of "The Very Best of Recipes for Health."

Monday, November 29, 2010

Health : Health Buzz: Scientists Partially Reverse Aging in Mice

Health : Health Buzz: Scientists Partially Reverse Aging in Mice


Health Buzz: Scientists Partially Reverse Aging in Mice

Posted: 29 Nov 2010 02:38 PM PST

This posting includes an audio/video/photo media file: Download Now

For Help With Medical Bills, Cut a Deal With the Doctor

Posted: 29 Nov 2010 12:53 PM PST

This posting includes an audio/video/photo media file: Download Now

Health Buzz: Alpha-Carotene Linked to Longer, Healthier Life

Posted: 29 Nov 2010 10:09 AM PST

Antioxidant in Orange Fruits and Vegetables Tied to Health Benefits

Go orange, at least when it comes to fruits and vegetables. Eating plentiful amounts of carrots, tangerines, and yes, even pumpkin pie may reward you with certain health benefits, new research suggests. People with high blood levels of alpha-carotene—an antioxidant found in orange-colored fruits and vegetables—live longer and are less like to die of heart disease and cancer than those with little or none of it in their bloodstream, according to a study that will be published in the March issue of the Archives of Internal Medicine. During a 14-year trial, researchers from the Centers for Disease Control and Prevention found that those with the highest concentrations of alpha-carotene were nearly 40 percent less likely to have died during the study than those with the lowest. Participants with medium levels, meanwhile, were 27 percent less likely to have died. But don't start popping alpha-carotene supplements, if you find them on drugstore shelves. Study authors say more research is needed to determine exactly how alpha-carotene-rich foods protect your health.

Think More Protein, Fewer Carbs to Maintain Weight Loss

It's a sad, well-worn fact that 90 percent of folks who lose weight fail to keep the pounds off. That abysmal success rate has left nutritionists scrambling to figure out how to help dieters maintain their weight loss without feeling like they have to stay on a "diet" in perpetuity, writes U.S. News's Deborah Kotz. Well, a new study published in the New England Journal of Medicine may provide a template for post-dieters to follow. It turns out, those who fill their plates with more protein and fewer processed carbohydrates—not all carbs are created equal—are better able to maintain their weight loss than those who eat a similar number of calories but shun protein for pasta, bagels, and bread. Processed carbs, often packed with sugar and white flour, fall into the category of high-glycemic index foods because they cause a rapid spike in blood sugar levels, which promotes the storage of body fat. "The results indicate that even a modest increase in dietary protein or a modest reduction in glycemic-index values was sufficient to minimize weight regain and promote further weight loss in obese patients after a successful weight-loss diet," write the Danish study authors.

The study included nearly 800 overweight volunteers who lost an average of 23 pounds by following a low-calorie diet and were then randomly assigned to one of several eating plans in an effort to prevent weight regain over six months. Weight regain was less in those assigned to eat higher amounts of protein and "low-glycemic index" carbohydrates like high-fiber fruits, vegetables, and whole grains compared to those who were told to eat less protein and more high-glycemic index foods like white rice, French fries, and sugary cereal. Those who ate more protein also were more likely to continue losing weight than those who ate mostly carbohydrates, even the unprocessed ones. [Read more: Think More Protein, Fewer Carbs to Maintain Weight Loss.]

For Health Benefits, Try Tai Chi

The gentle, 2,000-year-old Chinese practice of tai chi is often described as "meditation in motion." But the Harvard Women's Health Watch newsletter suggests a more apt description is "medication in motion," Courtney Rubin writes for U.S. News.

Tai chi, the most famous branch of Qigong, or exercises that harness the qi (life energy, pronounced "chee"), has been linked to health benefits for virtually everyone from children to seniors. Researchers aren't sure exactly how, but studies show that tai chi improves the quality of life for breast cancer patients and Parkinson's sufferers. Its combination of martial arts movements and deep breathing can be adapted even for people in wheelchairs. And it has shown promise in treating sleep problems and high blood pressure.

Flexibility and strength. Tai chi is credited with so many pluses, physiological and psychological, that Chenchen Wang, an associate professor of medicine at Tufts University, set out earlier this year to analyze 40 studies on it in English and Chinese journals. Wang found that tai chi did indeed promote balance, flexibility, cardiovascular fitness, and strength. In a study comparing it with brisk walking and resistance training, a tai chi group improved more than 30 percent in lower-body strength and 25 percent in arm strength, nearly as much as a weight-training group and more than the walkers. [Read more: For Health Benefits, Try Tai Chi.]

This posting includes an audio/video/photo media file: Download Now

Women With Breast Cancer History Should Consider MRI: Study

Posted: 29 Nov 2010 06:00 AM PST

This posting includes an audio/video/photo media file: Download Now

Rate of Eating Disorders in Kids Keeps Rising

Posted: 29 Nov 2010 06:00 AM PST

This posting includes an audio/video/photo media file: Download Now

Health - Fuel Lines of Tumors Are Target in Cancer Fight

Health - Fuel Lines of Tumors Are Target in Cancer Fight


Fuel Lines of Tumors Are Target in Cancer Fight

Posted: 29 Nov 2010 12:48 PM PST

For the last decade cancer drug developers have tried to jam the accelerators that cause tumors to grow. Now they want to block the fuel line.

The University of Alberta

TACTICS Dr. Evangelos Michelakis of the University of Alberta is working on a method to encourage cell suicide.

Related

Cancer cells, because of their rapid growth, have a voracious appetite for glucose, the main nutrient used to generate energy. And tumors often use glucose differently from healthy cells, an observation first made by a German biochemist in the 1920s.

That observation is already used to detect tumors in the body using PET scans. A radioactive form of glucose is injected into the bloodstream and accumulates in tumors, lighting up the scans.

Now, efforts are turning from diagnosis to treating the disease by disrupting the special metabolism of cancer cells to deprive them of energy.

The main research strategy of the last decade has involved so-called targeted therapies, which interfere with genetic signals that act like accelerators, causing tumors to grow. But there tend to be redundant accelerators, so blocking only one with a drug is usually not enough.

In theory, however, depriving tumors of energy should render all the accelerators ineffective.

“The accelerators still need the fuel source,” said Dr. Chi Dang, a professor of medicine and oncology at Johns Hopkins University. Indeed, he said, recent discoveries show that the genetic growth signals often work by influencing cancer cells’ metabolism.

The efforts to exploit cancer’s sweet tooth are in their infancy, with few drugs in clinical trials. But interest is growing among pharmaceutical companies and academic researchers.

“Nutrient supply and deprivation is becoming potentially the next big wave,” said Dr. David Schenkein, chief executive of Agios Pharmaceuticals, a company formed two years ago to develop drugs that interfere with tumor metabolism. Among its founders was Dr. Craig B. Thompson, the new president of Memorial Sloan-Kettering Cancer Center in New York City.

Other small companies, like Cornerstone Pharmaceuticals and Myrexis, are pursuing the approach, and big drug companies are also jumping in. Earlier this year, AstraZeneca agreed to work with Cancer Research UK, a British charity, on drugs that interfere with cancer metabolism.

One factor spurring interest in cancer metabolism is the intriguing interplay between cancer and diabetes, a metabolic disease marked by high levels of blood glucose. The possible link between the two great scourges has garnered so much attention that the American Cancer Society and the American Diabetes Association jointly published a consensus statement this summer summarizing the evidence.

People with Type 2 diabetes tend to have a higher risk of getting certain cancers. And preliminary evidence suggests that metformin, the most widely used diabetes pill, might be effective in treating or preventing cancer.

It is still not clear if high blood glucose is the reason diabetics have a higher cancer risk. A more likely explanation is that people with Type 2 diabetes have high levels of insulin, a hormone that is known to promote growth of certain tumors, according to the consensus statement.

Similarly, metformin might fight cancer by lowering insulin levels, not blood sugar levels. But there is some evidence that the drug works in part by inhibiting glucose metabolism in cancer cells.

Even if blood sugar levels fuel tumor growth, however, experts say that trying to lower the body’s overall level of blood sugar — like by starving oneself — would probably not be effective. That is because, at least for people without diabetes, the body is very good at maintaining a certain blood glucose level despite fluctuations in diet.

“When a patient with cancer is calorically restricted, the amount of glucose in the blood until they are almost dead is close to normal,” said Dr. Michael Pollak, professor of medicine and oncology at McGill University in Montreal. Also, Dr. Pollak said, tumors are adept at extracting glucose from the blood. So even if glucose is scarce, he said, “the last surviving cell in the body would be the tumor cell.”

So efforts are focusing not on reducing the body’s overall glucose level but on interfering specifically with how tumors use glucose.

This gets to the Warburg effect, named after Otto Warburg, the German biochemist and Nobel Prize winner who first noticed the particular metabolism of tumors in the 1920s.

Most healthy cells primarily burn glucose in the presence of oxygen to generate ATP, a chemical that serves as a cell’s energy source. But when oxygen is low, glucose can be turned into energy by another process, called glycolysis, which produces lactic acid as a byproduct. Muscles undergoing strenuous exercise use glycolysis, with the resultant buildup of lactic acid.

What Dr. Warburg noticed was that tumors tended to use glycolysis even when oxygen was present. This is puzzling because glycolysis is far less efficient at creating ATP.

One theory is that cancer cells need raw materials to build new cells as much as they need ATP. And glycolysis can help provide those building blocks.

“You can have energy that turns on the lights in your house, but that energy can’t build anything,” said Matthew G. Vander Heiden, assistant professor of biology at the Massachusetts Institute of Technology.

Still, as with everything else about cancer, metabolism is complex. Not all tumor cells use glycolysis, and some normal cells do. So it could be challenging to develop drugs that can hurt tumors but not normal cells.

Two early efforts by a company called Threshold Pharmaceuticals to interfere with glucose metabolism did not work well in clinical trials. One of Threshold’s drugs, called 2DG, is the same form of glucose used in PET imaging, but without the radioactivity. Because of a slight chemical modification, this form of glucose cannot be metabolized by cells, so it accumulates.

Personal Best: Fell Off My Bike, and Vowed Never to Get Back On

Posted: 29 Nov 2010 12:00 PM PST

I crashed on my bike on Oct. 3 and broke my collarbone, an experience so horrific that my first impulse was to say I would never ride on the road again.

Well

Share your thoughts on this column at the Well blog.

Go to Well »

Turns out I am not alone.

“Well, you’ve joined the proud majority of serious cyclists who’ve busted a collarbone,” said Rob Coppolillo, a competitive cyclist in Boulder, Colo., who also leads rock- and ice-climbing expeditions and is a part-time ski guide.

I’ve since heard from other cyclists who broke bones or were badly bruised and shaken up in crashes. Many say they, too, vowed, at least initially, never to ride outside again. It’s not a universal response, but it is so common that cyclists nod their heads when they hear my reaction to my injury.

Yet almost no one swears off running after an injury, even though — and I speak from experience — a running injury can keep you away from your sport at least as long. And that made me wonder: is a cycling injury qualitatively different from a running injury? Is it the drama of a crash, or is it that a crash makes you realize you could actually be killed on a bike? Is it the type of injury? Or the fact that you can feel, as I did, that the accident was unfair and out of your control?

Risk-assessment experts say that it is all of the above, and that the way we respond to various sports injuries reveals a lot about how we assess risks.

My crash came 8.9 miles into a 100-mile ride (of course I knew the distance, because of course I was watching my bicycle computer). My friend Jen Davis was taking a turn leading; my husband, Bill, was drafting — riding close behind her. I was drafting Bill when a slower rider meandered into his path. Bill swerved and I hit his wheel. Down I went.

The first thing I did when I hit the ground was turn off my stopwatch — I did not want accident time to count toward our riding time. Then I sat on a curb, dazed. My head had hit the road, but my helmet saved me. My left thigh was so bruised it was hard to walk. Worst of all was a searing pain in my left shoulder. I could hardly move my arm. But since it hurt whether I rode or not, I decided, like an idiot, to finish the ride.

The next day I went to a doctor and learned, to my shock, that my collarbone was broken. Running is my sport, I thought, and no ride is worth this.

I remembered what Michael Berry, an exercise physiologist at Wake Forest University, once told me. With cycling, he said, it’s not if you crash, it’s when. He should know. He’s a competitive cyclist whose first serious injury — a broken hip — happened when he crashed taking a sharp turn riding down a mountain road.

Then, last June, he was warming up for a race when he hit a squirrel, crashed into a telephone pole and broke his arm so badly he needed surgery.

His reaction to each crash was a variant of mine. He’d taken up cycling about five years ago because he’d injured his hamstring running. “With each wreck I thought, ‘Maybe I should try running again,’ ” he said.

My running friend Claire Brown, a triathlete, crashed a few years ago when she was riding fast on wet roads, getting in one last training ride before a race. Her bike slid on a metal plate in a bridge and she went down, hitting her head and her left hip. She was badly bruised, and even though she broke no bones, she did not feel comfortable riding for the next two years. Even now, she told me, “there are bridges around here I won’t ride on, and I definitely won’t go downhill fast.”

And yet, and yet. Despite how much it hurt, my collarbone fracture was nowhere near as bad as some running injuries. When I got a stress fracture — a hairline break — in a small bone in my foot, I was on crutches for eight weeks. When I finally could run again, my foot hurt because the muscles had atrophied. Running was slow and difficult. I’d lost the rhythm and the stride that make running fun.

With the collarbone fracture, I wore a sling for three weeks but could take it off and ride my bike on my trainer — a device that turns a road bike into a stationary one — and use an elliptical cross-trainer. After four weeks I could run, and running felt good.

George Loewenstein, a professor of economics and psychology at Carnegie Mellon University, says there are several factors that separate running injuries from cycling ones.

Mind: A Fate That Narcissists Will Hate: Being Ignored

Posted: 29 Nov 2010 12:30 PM PST

Narcissists, much to the surprise of many experts, are in the process of becoming an endangered species.

Scott Menchin

Well

Share your thoughts on this column at the Well blog.

Go to Well »

Not that they face imminent extinction — it’s a fate much worse than that. They will still be around, but they will be ignored.

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (due out in 2013, and known as DSM-5) has eliminated five of the 10 personality disorders that are listed in the current edition.

Narcissistic personality disorder is the most well-known of the five, and its absence has caused the most stir in professional circles.

Most nonprofessionals have a pretty good sense of what narcissism means, but the formal definition is more precise than the dictionary meaning of the term.

Our everyday picture of a narcissist is that of someone who is very self-involved — the conversation is always about them. While this characterization does apply to people with narcissistic personality disorder, it is too broad. There are many people who are completely self-absorbed who would not qualify for a diagnosis of N.P.D.

The central requirement for N.P.D. is a special kind of self-absorption: a grandiose sense of self, a serious miscalculation of one’s abilities and potential that is often accompanied by fantasies of greatness. It is the difference between two high school baseball players of moderate ability: one is absolutely convinced he’ll be a major-league player, the other is hoping for a college scholarship.

Of course, it would be premature to call the major-league hopeful a narcissist at such an early age, but imagine that same kind of unstoppable, unrealistic attitude 10 or 20 years later.

The second requirement for N.P.D.: since the narcissist is so convinced of his high station (most are men), he automatically expects that others will recognize his superior qualities and will tell him so. This is often referred to as “mirroring.” It’s not enough that he knows he’s great. Others must confirm it as well, and they must do so in the spirit of “vote early, and vote often.”

Finally, the narcissist, who longs for the approval and admiration of others, is often clueless about how things look from someone else’s perspective. Narcissists are very sensitive to being overlooked or slighted in the smallest fashion, but they often fail to recognize when they are doing it to others.

Most of us would agree that this is an easily recognizable profile, and it is a puzzle why the manual’s committee on personality disorders has decided to throw N.P.D. off the bus. Many experts in the field are not happy about it.

Actually, they aren’t happy about the elimination of the other four disorders either, and they’re not shy about saying so.

One of the sharpest critics of the DSM committee on personality disorders is a Harvard psychiatrist, Dr. John Gunderson, an old lion in the field of personality disorders and the person who led the personality disorders committee for the current manual.

Asked what he thought about the elimination of narcissistic personality disorder, he said it showed how “unenlightened” the personality disorders committee is.

“They have little appreciation for the damage they could be doing.” He said the diagnosis is important in terms of organizing and planning treatment.

“It’s draconian,” he said of the decision, “and the first of its kind, I think, that half of a group of disorders are eliminated by committee.”

He also blamed a so-called dimensional approach, which is a method of diagnosing personality disorders that is new to the DSM. It consists of making an overall, general diagnosis of personality disorder for a given patient, and then selecting particular traits from a long list in order to best describe that specific patient.

This is in contrast to the prototype approach that has been used for the past 30 years: the narcissistic syndrome is defined by a cluster of related traits, and the clinician matches patients to that profile.

The dimensional approach has the appeal of ordering à la carte — you get what you want, no more and no less. But it is precisely because of this narrow focus that it has never gained much traction with clinicians.

It is one thing to call someone a neat and careful dresser. It is another to call that person a dandy, or a clotheshorse, or a boulevardier. Each of these terms has slightly different meanings and conjures up a type.

And clinicians like types. The idea of replacing the prototypic diagnosis of narcissistic personality disorder with a dimensional diagnosis like “personality disorder with narcissistic and manipulative traits” just doesn’t cut it.

Jonathan Shedler, a psychologist at the University of Colorado Medical School, said: “Clinicians are accustomed to thinking in terms of syndromes, not deconstructed trait ratings. Researchers think in terms of variables, and there’s just a huge schism.” He said the committee was stacked “with a lot of academic researchers who really don’t do a lot of clinical work. We’re seeing yet another manifestation of what’s called in psychology the science-practice schism.”

Schism is probably not an overstatement. For 30 years the DSM has been the undisputed standard that clinicians consult when diagnosing mental disorders. When a new diagnosis is introduced, or an established diagnosis is substantially modified or deleted, it is not a small deal. As Dr. Gunderson said, it will affect the way professionals think about and treat patients.

Given the stakes, the blow-back from experts in personality disorders should come as no surprise.

Dr. Gunderson has written a letter co-signed by other clinical and research leaders to the trustees of the American Psychiatric Association and the task force that governs DSM-5. And Dr. Shedler and seven colleagues published an editorial in the September issue of The American Journal of Psychiatry. In the relatively small world of mental health diagnostics, this is most certainly a battle worth watching.

Right now, this much seems clear: It is way too early for the narcissists to give up their seat on the bus.

Charles Zanor is a psychologist in West Springfield, Mass.

Charles Zanor is a psychologist in West Springfield, Mass.

Inefficiency Hurts U.S. In Ranking of Health

Posted: 29 Nov 2010 12:12 PM PST

By any measure, the United States spends more on health care than any other nation. Yet according to the World Fact Book (published by the Central Intelligence Agency), it ranks 49th in life expectancy.

Why?

Researchers writing in the November issue of the journal Health Services say they know the answer. After citing statistical evidence showing that American patterns of obesity, smoking, traffic accidents and homicide are not the cause of lower life expectancy, they conclude that the problem is the health care system.

Peter A. Muennig and Sherry A. Gleid, researchers at the Mailman School of Public Health at Columbia University, compared the performance of the United States and 12 other industrialized nations: Australia, Austria, Belgium, Britain, Canada, France, Germany, Italy, Japan, the Netherlands, Sweden and Switzerland. In addition to health care expenditures in each country, they focused on two other important statistics: 15-year survival for people at 45 years and for those at 65 years.

The researchers say those numbers present an accurate picture of public health because they measure a country’s success in preventing and treating the most common causes of death — cardiovascular disease, stroke and diabetes — which are more likely to occur at these ages. Their data come from the World Health Organization and cover 1975 to 2005.

Life expectancy increased over those years in all 13 countries, and so did health care costs. But the United States had the lowest increase in life expectancy and the highest increase in costs.

In 1975 the United States was close to the average in health care costs, and last in 15-year survival for 45-year-old men. By 2005 its costs had more than tripled, far surpassing increases elsewhere, but the survival number was still last — a little over 90 percent, compared with more than 94 percent for Swedes, Swiss and Australians. For women, it was 94 percent in the United States, versus 97 percent in Switzerland, Australia and Japan.

The numbers for 65-year-olds in 2005 were similar: about 58 percent of American men could be expected to survive 15 years, compared with more than 65 percent of Australians, Japanese and Swiss. While more than 80 percent of 65-year-old women in France, Switzerland, and Japan would survive 15 years, only about 70 percent of American women could be expected to live that long.

In narrowing the blame to the American health care system, the researchers first eliminated several other factors. Obesity and smoking are the most important behavior-related causes of death, but obesity increased more slowly in the United States than in the other countries and smoking declined more rapidly, so neither can explain the differences in survival rates. Homicide and traffic fatality rates have remained steady over time, and social, economic and educational factors do not vary greatly among these countries.

But not all experts agree with this analysis. Samuel Preston, a demographer and a professor of sociology at the University of Pennsylvania, says the analysis is faulty.

“The basic message is correct — that measures of U.S. health, including mortality and morbidity, are very poor in comparison with other countries,” he said. But the Columbia researchers “have no direct evidence about the health care system in this article,” he continued. “Their conclusion is extremely speculative.”

That they did not find smoking at fault, Dr. Preston said, “is mysterious to me, particularly since they show high lung cancer mortality for the U.S.” Dr. Preston has published widely on mortality trends and the effects of smoking.

Dr. Muennig conceded that the study examined only life expectancy and health care spending in the 13 countries, and not the structure or economics of health care. “We did a pretty good job of showing that smoking isn’t the culprit,” he said.

“Smoking and obesity are still major risk factors for an individual’s health,” he said. “But they are sapping life expectancy in all countries. Whereas in the U.S. we have a highly inefficient health system that’s taking away financial resources from other lifesaving programs.”

Global Update: Sierra Leone: Outbreak of Mysterious Blisters Is Case Study in Spread of Panic

Posted: 29 Nov 2010 12:11 PM PST

An outbreak of mysterious blisters in Sierra Leone illustrates how panic can be stirred by a combination of overwrought journalism, listless government and traditional witchcraft.

The Inquirer, a Sierra Leone news site cited on ProMed, an epidemic-alert service, reported that “the wild spread of the contagious skin disease” was taking over a rural county, with 75 people affected. It quoted local residents blaming polluted water, “poisonous bacteria” or “contamination of the underground,” and said a government minister had “warned people with the disease to cease all movement.”

In fact, a careful reading of the article suggested that local doctors had identified a plausible cause and suggested a sensible solution. But that point was obscured by the purple “Fear Grips City” prose.

The blisters, the doctors said, were from “Nairobi flies,” and their advice was to just blow them off, not slap them. The “Nairobi fly” is actually a red-and-black beetle of the genus Paederus that is found from India to West Africa but hatches only rarely. It does not bite, but contains pederin, a stinging acid, to drive off predators. Smacking it on the skin releases the acid, which can leave a nasty welt; touching an eye with the acid can blind it for days. The condition is, of course, not contagious.

While this brouhaha may seem minor, others have had serious consequences. Nigeria’s polio vaccination drive, for example, was derailed by journalists spreading rumors that the vaccine was a plot to sterilize Muslim girls; polio then spread from Nigeria to more than a dozen other countries.

Vital Signs: Diet: Good-for-You Things Come in Orange

Posted: 29 Nov 2010 12:31 PM PST

Eat your carrots. And have some leftover pumpkin pie.

People with high blood levels of alpha-carotene — an antioxidant found in orange fruits and vegetables — live longer and are less likely to die of heart disease and cancer than people who have little or none of it in their bloodstream, a new study reports.

The study does not prove a cause-and-effect relationship, only an association.

Still, its results are intriguing. Researchers from the Centers for Disease Control and Prevention analyzed alpha-carotene levels in blood samples from more than 15,000 adults who participated in a follow-up study of the third National Health and Nutrition Examination Survey from 1988 to 1994. By 2006, researchers determined, 3,810 of the participants had died. Those with the highest levels of alpha-carotene were more likely to have survived, even after the scientists controlled for variables like age and smoking.

Those with the highest concentrations of the antioxidant were almost 40 percent less likely to have died than those with the lowest; those with midrange levels were 27 percent less likely to die than those with the lowest levels.

“It’s pretty dramatic,” said the lead author, Dr. Chaoyang Li, a C.D.C. epidemiologist. The study was published online Nov. 22 in Archives of Internal Medicine.

Vital Signs: Aging: Unsteady on Your Feet? Try Moving to Music

Posted: 29 Nov 2010 12:31 PM PST

Elderly people in a new study cut their risk of falling by more than half after they took classes in eurhythmics, an exercise-and-music program designed for young children.

The 12-month trial recruited 134 people, average age 75, who were unsteady on their feet. Half were randomly assigned to weekly hourlong eurhythmics classes for the first six months, and the other half took no classes until the following six months.

The program, developed by the early-20th-century Swiss composer Émile Jaques-Dalcroze, teaches movement in time to music, from Mozart minuets to jazz improvisations. Participants have to walk and turn around, stay in step with changing tempos, learn to shift their weight and balance, handle objects while walking, and make exaggerated upper-body movements while walking.

The two groups were monitored to determine how many times they fell. In the first group, there were just 24 falls over the first six months, compared with 54 among those who were not in the classes.

Even after the classes ended, the participants maintained their improvements in balance, walked with a more regular gait and were better able to walk while doing other things. The study was published online in Archives of Internal Medicine.

The paper’s lead author, Dr. Andrea Trombetti of the University Hospitals and Faculty of Medicine of Geneva, said that despite the results, it was still unclear how music affected walking.

Recipes for Health: Turkey: Not Just for Thanksgiving

Posted: 29 Nov 2010 10:10 AM PST

Too often, cooks think about what to make with turkey only when faced with a deluge of Thanksgiving leftovers. Your refrigerator may still be stuffed with them even now, well after the holiday. But there are plenty of reasons for cooks to get better acquainted with turkey.

Recipes for Health

Martha Rose Shulman presents food that is vibrant and light, full of nutrients but by no means ascetic, fun to cook and to eat.

Above all else, turkey is versatile. Combining turkey with grains is one way to make meals high in protein and low in fat. Toss shredded turkey with grain pilaf, celery, fresh herbs, a vinaigrette and a few vegetables, and you’ve got a terrific main dish salad. You can use turkey in a risotto. Or how about a casserole? The turkey casserole I’ve chosen this week is Middle Eastern, spiced with allspice and cinnamon and topped with thick yogurt.

Turkey also can substitute for chicken in your favorite tacos and enchiladas, salads, chilaquiles and soups. A while back, I devoted a week of columns to dishes you can make with shredded poached chicken breasts; turkey will work in any of those dishes just as well.

Turkey Tacos With Green Salsa

These tacos are reason enough to keep a bottle of green salsa on hand in your pantry. They are easily thrown together, even if you choose to make your own salsa.

2 cups shredded turkey

1 cup green salsa, bottled or homemade

4 radishes, thinly sliced or cut in julienne

1/4 cup chopped cilantro

1 small ripe avocado, diced

Salt

8 corn tortillas

1 cup shredded lettuce

Juice of 1 lime

1/3 cup queso fresco

1. Combine the turkey, salsa, radishes, cilantro and avocado in a bowl. Season with salt to taste.

2. Heat the tortillas individually in a dry pan or microwave. Alternately, wrap them in a kitchen towel and place in a steamer above 1 inch of boiling water for one minute. Turn off the heat, and let sit covered for 10 minutes.

3. Place two tortillas on each plate, and top with the turkey mixture. Top the turkey mixture with shredded lettuce, squeeze on some lime juice, sprinkle with queso fresco and serve.

Yield: Four servings.

Advance preparation: This is thrown together just before serving. Homemade salsa will keep for a couple of days in the refrigerator.

Nutritional information per serving: 303 calories; 12 grams fat; 3 grams saturated fat; 60 milligrams cholesterol; 23 grams carbohydrates; 6 grams dietary fiber; 129 milligrams sodium (does not include salt added during preparation); 26 grams protein

Martha Rose Shulman is the author of "The Very Best of Recipes for Health."

Gates Seeking to Contain Military Health Costs

Posted: 29 Nov 2010 02:16 AM PST

WASHINGTON — Francis Brady enjoys a six-figure salary and generous benefits at the consulting firm Booz Allen Hamilton, but as a retired Marine lieutenant colonel he and his family remain on the military’s bountiful lifetime health insurance, Tricare, with fees of only $460 a year. He calls the benefit “phenomenal.”

Brendan Smialowski for The New York Times

Francis Brady, a retired Marine lieutenant colonel, says Tricare is “phenomenal,” much cheaper than a private-sector plan.

“It is so cheap compared to what Booz Allen has,” Colonel Brady said in a recent interview, acknowledging that premiums called for by private employers can run many times greater.

Of nearly 4.5 million military retirees and their families, about three-quarters are estimated to have access to health insurance through a civilian employer or group. But more than two million of them stay on Tricare. As the costs of private health care continue to climb, their numbers are only expected to grow.

Now, as part of a broad offensive to cut Pentagon spending, that group is once again in the sights of Defense Secretary Robert M. Gates, who is seriously considering whether to ask for Tricare fee increases in next year’s budget — and perhaps start one of the last fights of his public career.

Already, he has met with the chairmen of President Obama’s bipartisan fiscal commission, which faces a deadline this week for getting an agreement on a plan to address the federal budget deficit.

The battle over Tricare pits the efforts of the Pentagon to contain the exploding cost of health care for nearly 10 million eligible beneficiaries against the pain and emotions of those who say they have already “paid up front” with service in uniform, particularly those who deployed to America’s two current wars. The 10 million figure includes active-duty personnel, retirees, members of the National Guard and Reserves and their families.

The arguments reflect the broader debate over the huge Pentagon budget that will intensify next year when Mr. Gates, who says he will step down in 2011, continues his campaign to cut off what he calls the “gusher” of defense spending. Total health care costs for the Pentagon, which is the nation’s single largest employer, top $50 billion a year, a tenth of its budget and about the same amount that it is spending this year on the war in Iraq. Ten years ago, health care cost the Pentagon $19 billion; five years from now it is projected to cost $65 billion.

But Tricare fees have not increased since 1995.

“Health care costs are eating the Defense Department alive,” Mr. Gates said in a much-noticed speech in May. Defense budget analysts say that rising health care costs will make less money available for new weapons, repairs to a worn-out arsenal and quality-of-life programs like schools on military bases.

“In the long run, it could actually limit our ability to field a military of sufficient size,” said Todd Harrison, a senior fellow for defense budget studies at the Center for Strategic and Budgetary Assessments in Washington.

Veterans groups and military officers’ lobbies have responded by going on high alert. One of the most powerful of them, the Military Officers Association of America, is preparing a public relations campaign that will focus on what it calls the broken promise between the nation and the people who defend it.

“Don’t ask the folks who have done so much more for this country, who have been called to act since 9/11, to be the first in line to give some more,” said Norbert R. Ryan Jr., a retired vice admiral and president of the military officers’ group. As for Tricare’s generous benefits, Admiral Ryan said that anyone “can get this good deal — go over to a recruiting office and sign up for Iraq and Afghanistan.”

Defense officials point out that Mr. Gates is weighing only whether to increase the cost of health insurance for retirees and their families, not those on active duty, who receive Tricare at no cost. Any fee increases would also not affect military retirees 65 and older, who use a free program called Tricare for Life that supplements Medicare. It is not possible to estimate the exact savings without knowing what rate increase might be proposed, but analysts say even a modest rise could recoup billions of dollars annually for the Pentagon.

If the past is any guide, veterans groups are expected to point out that any fee increases could affect those disabled by the wars in Iraq or Afghanistan who do not use the free services available to them at veterans’ hospitals, either because they choose not to or because they live too far away.

Mr. Gates has included proposals to increase Tricare fees for retirees in three of his past four Pentagon budgets. In 2008, when he held the same job under the Bush administration, Mr. Gates proposed a five-year phased increase of the annual $460 family fee for Tricare Prime, the popular H.M.O.-like option offered to military retirees, to a maximum of $1,260 to $2,460, depending on a retiree’s income, according to an analysis by the Congressional Budget Office.

Tricare refers to the $460 payment as an “enrollment fee,” not a premium. With $12 co-pays per doctor visit, some drug prescription payments and other costs, the current annual out-of-pocket expense for a family on Tricare Prime is estimated at $1,200 per year, still substantially less than what is available from private employers.

Congress, unwilling to be seen as inflicting any kind of pain on the military or veterans, rejected the increases. Mr. Gates said he got the message — “The proposals routinely die an ignominious death on Capitol Hill,” he said in May — and he did not try again in 2010. But in shaping that budget proposal, Obama administration officials also told the Pentagon not to raise it, lest it distract from Mr. Obama’s overhaul of the nation’s health care system earlier this year.

Some Pentagon officials and military advocacy groups have suggested alternatives to raising fees that could cut costs. One idea is to renegotiate the lucrative Tricare packages with the insurance companies, hospitals and drug companies that actually operate the programs. Another is to promote a cost-saving mail-order pharmacy.

Defense officials say that Mr. Gates has to make up his mind about any health care fee increases in the next weeks, in time for the Pentagon to submit its 2012 spending plans to the White House budget director in December. Defense analysts who spoke to Mr. Gates over the summer said he told them that he did not know if it was realistic to try to increase military health care costs while troops were at war.

But Defense Department officials have since said they see a window of opportunity in the growing alarm over the federal debt, the focus of two bipartisan panels that are proposing deep cuts in government spending.

Mr. Gates met in recent weeks with the leaders of one of the panels, former Senator Alan K. Simpson, a Republican, and Erskine B. Bowles, a Democrat and the former chief of staff to President Bill Clinton. They are the co-chairmen of Mr. Obama’s fiscal commission, which has proposed raising Tricare fees. The panel is trying to deliver a final report to the White House on Wednesday, if the members can reach a consensus that fast.

The panel is considering proposals to increase fees for military retirees working for civilian companies, but it would also require employers to reimburse the government for a share of the health insurance costs of those on their payroll who opt for Tricare. That measure alone, described as an effort to make civilian employers pay “a normal business expense,” could recoup $3 billion annually for the Pentagon.

In the meantime, Colonel Brady, 51, said he did not want to be overly dramatic about what was at stake. Although he spent 22 years in the Marines, six of them deployed, including to the 1991 Persian Gulf war, he said he could not buy the argument about a broken promise.

“Tricare is a very good deal for me, and if it costs some more, well, O.K.,” he said. Raising Tricare fees would be a financial burden for many retirees, he acknowledged, but he could not honestly say it would be for him.

“Not that I want to pay a ton of money,” he said.

An AIDS Advance, Hiding in the Open

Posted: 27 Nov 2010 09:20 PM PST

In the war against AIDS, a new weapon has emerged.

It wasn’t a secret weapon. It was a well-established treatment pill that has only now been shown to be effective as a prevention pill too. Which raises a question: What took so long?

Last week, a clinical trial showed that taking Truvada, a pill combining two drugs, once a day would greatly reduce a gay man’s chances of getting infected with the dangerous virus. Although confirmatory studies are still needed, the practice — called “pre-exposure prophylaxis,” or “prep” — will, in theory, also protect sex workers, needle sharers, wives of infected men, prison inmates and anyone else at risk.

But Truvada has been sold since 2004. And the world has known since 1995 that antiretroviral drugs, used in combination, can rescue people with AIDS. As far back as at least 1990, it also knew that “post-exposure prophylaxis” (“pep”) often works in humans — that is, that a victim of a needle stick or rape or unprotected sex who begins taking a short course of antiretrovirals within 72 hours can probably avoid infection.

A few scientists even knew by 1995 that a drug in Truvada can protect monkeys from infection with the simian version of the AIDS virus.

So couldn’t “prep” have been “discovered” earlier? Why did it take until 2010?

The delay turns out to be a combination of scientific caution and the fiery politics of AIDS. While a medical advance can be made by a momentary flash of inspiration or luck — as legendarily happened with penicillin — proving that it works can take forever. And that is particularly true with AIDS, a disease surrounded by visceral fears, longstanding prejudices and the potential for huge profits.

The chief reason this advance took so long, said Dr. Robert M. Grant, a virologist at the Gladstone Institutes in San Francisco and the study’s chief author, is that the two drugs in Truvada, tenofovir and emtricitabine, were not approved for use in humans until 2001 and 2002, respectively. Older drugs, like AZT, the first AIDS drug, adopted in 1987, were too toxic.

Doctors once debated using nevirapine, approved in 1996. In poor countries, single doses for mother and baby are given at birth to prevent mother-child transmission. But taking nevirapine for even a few weeks can bring on brutal side effects. Over 10 percent of users get rashes. In rare cases, the drug can kill if not stopped in time.

Giving powerful drugs to healthy people is different from giving them to the desperately ill. No doctor would give cancer drugs to a healthy person. Prophylaxis is common with, for example, malaria drugs for travelers making brief sojourns in the tropics. But a drug to be taken all one’s life — or at least for all of one’s sex life — must be very safe.

Also, the drug must not prompt drug-resistance mutations in the virus. Tenofovir is unique that way, said Dr. Howard S. Jaffe, president of the Gilead Foundation, the philanthropic arm of Gilead Sciences, which makes Truvada. Structurally, it is so nearly identical to the bit of DNA it blocks that “the virus can’t easily outsmart it,” he said. Resistance to nevirapine, by contrast, can develop after a single dose.

Another factor is that not every drug company wants to see its best treatment drugs, on which it earns billions of dollars, tested for prevention. Dying patients accept unpleasant side effects; healthy ones might sue. And any patient who gets infected, even if taking the drug improperly, could sue. Gilead Sciences was willing to let Truvada be tested, although it has not yet decided, Dr. Jaffe said, whether to apply for F.D.A. permission to sell it as prophylaxis.

Also, several AIDS experts said, lab scientists were focused for years on the dream of an AIDS vaccine, while behaviorists assumed everyone would adopt condoms or abstinence. None of those hopes has been realized.

Health Law Faces Threat of Undercut From Courts

Posted: 29 Nov 2010 10:31 AM PST

WASHINGTON — As the Obama administration presses ahead with the health care law, officials are bracing for the possibility that a federal judge in Virginia will soon reject its central provision as unconstitutional and, in the worst case for the White House, halt its enforcement until higher courts can rule.

Blogs

The Caucus

The latest on President Obama, the new Congress and other news from Washington and around the nation. Join the discussion.

The judge, Henry E. Hudson of Federal District Court in Richmond, has promised to rule by the end of the year on the constitutionality of the law’s requirement that most Americans obtain insurance, which takes effect in 2014.

Although administration officials remain confident that it is constitutionally valid to compel people to obtain health insurance, they also acknowledge that Judge Hudson’s preliminary opinions and comments could presage the first ruling against the law.

“He’s asked a number of questions that express skepticism,” said one administration official who is examining whether a ruling against part of the law would undermine other provisions. “We have been trying to think through that set of questions,” said the official, who insisted on anonymity because he was not authorized to discuss the case freely.

While many newly empowered Republican lawmakers have vowed to repeal the health care law in Congress, a more immediate threat may rest in the federal courts in cases brought by Republican officials in dozens of states. Not only would an adverse ruling confuse Americans and attack the law’s underpinnings, it could frustrate the steps hospitals, insurers and government agencies are taking to carry out the law.

“Any ruling against the act creates another P.R. problem for the Democrats, who need to resell the law to insured Americans,” said Jonathan Oberlander, a University of North Carolina political scientist, who wrote in The New England Journal of Medicine last week that such a ruling “could add to health care reform’s legitimacy problem.”

So far, there has been only one ruling on the merits among nearly two dozen legal challenges to the health care act. Last month, a federal district judge in Michigan upheld the law. But another judge, Roger Vinson of Federal District Court in Pensacola, Fla., has joined Judge Hudson in writing preliminary opinions that seemingly accept key arguments made by state officials challenging the law.

Unlike the judge in Michigan, who was appointed by President Bill Clinton, both Judge Hudson and Judge Vinson were appointed by Republican presidents.

“We are not operating under the assumption that those two judges are inevitably going to rule against us,” the administration official said. “But of course we’re planning for the possibility that judges will reach different conclusions.”

The novel question before the courts is whether the government can require citizens to buy a commercial product like health insurance.

Because the Supreme Court has said the commerce clause of the Constitution allows Congress to regulate “activities that substantially affect interstate commerce,” the judges must decide whether the failure to obtain insurance can be defined as an “activity.”

Lawyers on both sides expect the issue eventually to be decided by the Supreme Court. But the appellate path to that decision could take two years. In the meantime, any district court judge who rules against the law would have to decide whether to block enforcement of one or more of its provisions, potentially creating bureaucratic chaos.

Such a decision would prompt a flurry of appeals, as the Justice Department almost certainly would ask the judge and then the appellate courts to stay, or delay, the injunction pending the outcome of higher court rulings.

Administration officials, as well as some lawyers for the plaintiffs, agree that Judge Hudson seems unlikely, based on his comments from the bench, to enjoin the entire law. The judge volunteered at a hearing last month that his courtroom was “just one brief stop on the way to the Supreme Court.”

If he does not enjoin the law, the immediate impact of a finding against the insurance mandate would be limited because that provision, and others that might fall with it, do not take effect for more than three years.

Virginia’s attorney general, Kenneth T. Cuccinelli II, a Republican who filed the Richmond lawsuit, argues that if Judge Hudson rejects the insurance requirement he should instantly invalidate the entire act on a nationwide basis.

Mr. Cuccinelli and the plaintiffs in the Florida case, who include attorneys general or governors from 20 states, have emphasized that Congressional bill writers did not include a “severability clause” that would explicitly protect other parts of the sprawling law if certain provisions were struck down.

The Vanishing Mind: Children Ease Alzheimer’s in Land of Aging

Posted: 26 Nov 2010 11:49 AM PST

SEONGNAM, South Korea — They were stooped, hobbled, disoriented, fumbling around the house. They got confused in the bathtub and struggled up stairs that seemed to swim before them.

The Vanishing Mind

War on Dementia

Articles in this series are examining the worldwide struggle to find answers about Alzheimer’s disease.

Multimedia
Todd Heisler/The New York Times

High school students in Seoul assisted a woman with dementia at the Cheongam nursing home, part of a broader “War on Dementia” by the South Korean government.

“Oh, it hurts,” said Noh Hyun-ho, sinking to the ground.

“I thought I was going to die,” said Yook Seo-hyun.

There was surprisingly little giggling, considering that Hyun-ho, Seo-hyun and the others were actually perfectly healthy 11- to 13-year-old children. But they had strapped on splints, weighted harnesses and fogged-up glasses, and were given tasks like “Doorknob Experience” and “Bathroom Experience,” all to help them feel what it was like to be old, frail or demented.

“Even though they are smiling for us, every day, 24 hours, is difficult for them,” Jeong Jae-hee, 12, said she learned. “They lose their memory and go back to childhood.”

It is part of a remarkable South Korean campaign to cope with an exploding problem: Alzheimer’s disease and other dementias. As one of the world’s fastest-aging countries, with nearly 9 percent of its population over 65 already afflicted, South Korea has opened a “War on Dementia,” spending money and shining floodlights on a disease that is, here as in many places, riddled with shame and fear.

South Korea is training thousands of people, including children, as “dementia supporters,” to recognize symptoms and care for patients. The 11- to 13-year-olds, for instance, were in the government’s “Aging-Friendly Comprehensive Experience Hall” outside Seoul. Besides the aging simulation exercise, they viewed a PowerPoint presentation defining dementia and were trained, in the hall’s Dementia Experience Center, to perform hand massage in nursing homes.

“ ‘What did I do with my phone? It’s in the refrigerator,’ ” said one instructor, explaining memory loss. “Have you seen someone like that? They may go missing and die on the street.”

In another striking move, South Korea is also pushing to make diagnoses early, despite there being scant treatment.

“This used to be hidden” and “there is still stigma and bias,” said Kim Hye-jin, director of senior policy for the Health and Welfare Ministry. But “we want to get them out of their shells, out of their homes and diagnosed” to help families adjust and give patients “a higher chance of being taken care of at home.”

Hundreds of neighborhood dementia diagnostic centers have been created. Nursing homes have nearly tripled since 2008. Other dementia programs, providing day care and home care, have increased fivefold since 2008, to nearly 20,000. Care is heavily subsidized.

And a government dementia database allows families to register relatives and receive iron-on identification numbers. Citizens encountering wanderers with dementia report their numbers to officials, who contact families.

To finance this, South Korea created a long-term-care insurance system, paid for with 6.6 percent increases in people’s national health insurance premiums. In 2009, about $1 billion of government and public insurance money was spent on dementia patients. Still, with the over-65 population jumping from 7 percent in 2000 to 14 percent in 2018 to 20 percent in 2026, dementia is straining the country, socially and economically.

“At least one family member has to give up work” to provide caregiving, said Kwak Young-soon, social welfare director for Mapo District, one of Seoul’s 25 geographic districts. Because South Korea encourages people to work well past retirement age, families may also lose dementia sufferers’ incomes.

Most families no longer have generations living together to help with caregiving, and some facilities have long waiting lists, but “we can’t keep building nursing homes,” Mr. Kwak said. “We call it a ghost. It’s basically eating up the whole house.”

Dementia Epidemic

South Korea is at the forefront of a worldwide eruption of dementia, from about 30 million estimated cases now to an estimated 100 million in 2050. And while South Korea’s approach is unusually extensive, even in the United States, the National Alzheimer’s Project Act was introduced this year to establish a separate Alzheimer’s office to create “an integrated national plan to overcome Alzheimer’s.” Supporters of the bill, currently in committee, include Sandra Day O’Connor, whose late husband had Alzheimer’s.

South Korea also worries that dementia, previously stigmatized as “ghost-seeing” or “one’s second childhood” could “dilute respect for elders,” Mr. Kwak said. “There’s a saying that even the most filial son or daughter will not be filial if they look after a parent for more than three years.”

So the authorities promote the notion that filial piety implies doing everything possible for elders with dementia, a condition now called chimae (pronounced chee-may): disease of knowledge and the brain which makes adults become babies. But South Korea’s low birth rate will make family caregiving tougher.

“I feel as if a tsunami’s coming,” said Lee Sung-hee, the South Korean Alzheimer’s Association president, who trains nursing home staff members, but also thousands who regularly interact with the elderly: bus drivers, tellers, hairstylists, postal workers. “Sometimes I think I want to run away,” she said. “But even the highest mountain, just worrying does not move anything, but if you choose one area and move stone by stone, you pave a way to move the whole mountain.”

Su-Hyun Lee contributed reporting from Seoul, South Korea.

Patient Money: Think Twice Before Signing Up for That Medical Credit Card

Posted: 26 Nov 2010 09:50 PM PST

IF you are like most people, you have probably used a credit card to pay some of your medical bills. With rising health costs and gaps in insurance coverage, it’s almost unavoidable.

Matthew Cavanaugh for The New York Times

Mark Rukavina, executive director of the Access Project, said medical cards might not be suited to people with limited financial resources. “But it’s usually people with limited resources who sign up,” he said.

Well

Share your thoughts on this column at the Well blog.

Go to Well »

Patients pay about $45 billion worth of health care costs with plastic, according to a report from McKinsey & Company. By 2015, that number could more than triple to an estimated $150 billion. And big finance companies and medical providers have taken note.

Companies like GE Money, Citibank and JPMorgan Chase have issued medical credit cards or lines of credit intended to be used specifically for elective health care expenses not covered by insurance, including certain dental procedures, Lasik surgery, some cosmetic surgery and even veterinary care. The cards are not used for continuing medical care or emergency room visits.

The issuers market these cards not so much to consumers but to doctors, dentists and other health care providers, who in turn offer them to patients as a payment option. Patients like medical credit cards because payments for care can be spread out over many months and the cards can be used at multiple providers. The providers have embraced them as a way of offloading billing headaches and expenses.

But even as medical credit cards become increasingly popular, they are getting more scrutiny — not much of it flattering. Critics and patient advocates claim that aggressive and misleading marketing tactics can lead to serious headaches for consumers.

In extreme cases, medical providers and associations marketing the cards have been accused of receiving financial incentives for signing up patients or of falsifying financial information to make it easier for patients to qualify for cards.

More commonly, critics say, patients may be led to assume that their providers are simply offering payment plans, not a credit card with all the potential fees, interest rate increases and the impact on credit scores that can entail.

“Ironically, these cards may be best suited to people who already have financial resources," said Mark Rukavina, executive director of the Access Project, a consumer advocacy group in Boston, and co-author of a study on medical debt. “But it’s usually people with limited resources who sign up.”

Consumer complaints concerning aggressive marketing tactics prompted the New York attorney general, Andrew M. Cuomo, to start an investigation into medical credit cards earlier this year. In Minnesota, the state attorney general, Lori Swanson, has filed lawsuits against two chiropractors whose staff is accused of signing up patients for medical credit cards without their knowledge.

A medical credit card is “one payment option among several a provider may offer and represents a very small component of health care financing for elective procedures,” said Stephen White, a spokesman for CareCredit, a medical credit card issued by GE Money. “Benefits to consumers include the ability to plan, budget and pay for certain elective health care procedures over time.”

Whether you view these cards as a convenient way to pay medical expenses or just another way for credit card companies to collect interest and fees, here are some things to consider if your provider approaches you.

ASK FOR ALTERNATIVES First, try to negotiate a lower fee with your provider; he may be more flexible than you think. Then ask about payment options. Your doctor may well offer a payment plan of his or her own, without the high interest rates often charged by a medical credit card company.

“I encourage people to negotiate with their provider, then get an extended payment plan directly from that office with a monthly payment and time period you are comfortable with,” said Mr. Rukavina. “I think most providers are willing to work for patients in this way.”

If you do opt for a payment plan, ask whether you will be paying the provider directly or a third party. If there’s a third party involved, you may well wind up with a medical credit card. If you choose to sign up for it, be sure you’ve read through the terms carefully and that you understand the interest rates and late payment fees.

If your income is low enough, be aware that you may qualify for a public assistance program, especially for dental costs.

DODGE THE HARD SELL “Some patients report feeling pressured by their clinics to use the card to pay for procedures or treatments they may not need or can’t afford,” Ms. Swanson said. That’s no surprise, since these cards are intended, at least in part, to drive more business to dentists, chiropractors, cosmetic and eye surgeons, weight loss programs, hearing aid dispensers and other providers.

But the intense marketing can lead to unethical behavior, according to Ms. Swanson.

One of the lawsuits filed by her office claims that staff members at a chiropractic office told patients they were not signing up for a credit card but rather just going through a credit check. Instead, Ms. Swanson charges, the staff members submitted applications in the patients’ names and falsified patient’s yearly income information to make sure they qualified.

If you sense you’re being pushed, that things are moving too quickly, remember that you don’t have to sign up for anything on the spot. Take a day or two to read through materials thoroughly and research your options.

BEWARE THOSE TEASER RATES Almost all medical credit cards claim zero percent financing. This is what makes them attractive: you can spread out your payments and pay no interest.

But it is important to read the fine print. As with most credit cards marketed this way, the zero percent rate lasts only for an initial promotional period, usually from six to 24 months. Once that time is up, you will start to pay interest — sometimes high interest.

For GE’s CareCredit, for instance, rates jump to 26.99 percent. (The company does offer a fixed rate of 14.9 percent for extended periods up to 60 months.)

High interest isn’t your only concern. Be sure to check your minimum payment, advised Ms. Swanson. If you pay only the minimum, your payments may extend beyond the zero percent financing period, and you’ll end up with the higher rate.

What’s more, if you make just one late payment or go over the initial promotion period, some cards will charge you a high interest rate retroactively on the original balance, Ms. Swanson noted. That can suddenly add hundreds of dollars to your bill.

PAY AS YOU GO Some providers will charge your medical card for an entire multivisit procedure, like a dental implant, all at once. If you change providers midway through, or do not go through the entire procedure for some other reason, it can be difficult and time-consuming to get a refund, warned Mr. Rukavina.

If you are entering into a treatment or procedure that will take more than one visit, make sure your provider is billing you by the visit, not in a lump sum.

You can find more background on medical credit cards from the Minnesota attorney general’s office at www.ag.state.mn.us/Consumer/Publications/HealthCareCreditCards.asp.

What Was I Thinking?

Posted: 28 Nov 2010 03:05 PM PST

In “Self Comes to Mind,” the eminent neurologist and neuroscientist Antonio Damasio gives an account of consciousness that might come naturally to a highly caffeinated professor in his study. He emphasizes wakefulness, self-awareness, reflection, rationality, “knowledge of one’s own existence and of the existence of surroundings.”

Illustration by Shannon May

SELF COMES TO MIND

Constructing the Conscious Brain

By Antonio Damasio

367 pp. Pantheon. $28.95

That is certainly one kind of consciousness, what one might call self-consciousness. But there is also a different kind, as anyone who knows what it is like to have a headache, taste chocolate or see red can attest. Self-consciousness is a sophisticated and perhaps uniquely human cognitive achievement. Phenomenal consciousness by contrast — what it is like to experience — is something we share with many animals. A person who is drunk or delirious or dreaming can be excruciatingly conscious without being wakeful, self-aware or aware of his surroundings.

The term “conscious” was first introduced into academic discourse by the Cambridge philosopher Ralph Cudworth in 1678, and by 1727, John Maxwell had distinguished five senses of the term. The ambiguity has not abated. Damasio’s distinctive contributions in “Self Comes to Mind” are an account of phenomenal consciousness, a conception of self­consciousness and, most controversially, a claim that phenomenal consciousness is dependent on self-consciousness.

Phenomenally conscious content — what distinguishes the experience of blue from the taste of chocolate — is, according to Damasio, a matter of associations that are processed in different brain areas at the same time. What makes a conscious state feel like something rather than nothing is explained as a fusion of mind and body in which neurons become “extensions of the flesh.” Self-consciousness is the result of a procession of neural maps of inner and outer worlds. What’s more, he argues, phenomenal consciousness depends on self-consciousness. Without a self, he writes, “the mind would lose its orientation. . . . One’s thoughts would be freewheeling, unclaimed by an owner. . . . What would we look like? Well, we would look unconscious.”

Even fish and lizards have a kind of minimal self, one that combines sensory integration with control of information processing and action. But Damasio’s self is not minimal. It is inflated with self-awareness, reflection, rationality, deliberation and knowledge of one’s existence and the existence of one’s surroundings, and this is what he ends up arguing a ­being needs in order to have phenomenal consciousness.

You may have sensed that I think there is a problem with Damasio’s emphasis on self-consciousness: indeed, “Self Comes to Mind” is mainly about self-­consciousness rather than experiential phenomenal consciousness. And the book is not about ­geology or underwear or many other things either. So what?

I can explain the problem by a brief detour into a different book, “The Origins of Consciousness in the Breakdown of the Bicameral Mind” (1976), by the American psychologist Julian Jaynes. Jaynes held that consciousness was invented by the ancient Greeks between 1400 and 600 B.C. He argued that there was a dramatic appearance of introspection in large parts of the “Odyssey,” as compared with large parts of the “Iliad,” which he claimed were composed at least a hundred years earlier. The philosopher W. V. Quine once told me that he thought Jaynes might be on to something until he asked Jaynes what it was like to perceive before consciousness was invented. According to Quine, Jaynes said it was like nothing at all — exactly what it is like to be a table or a chair. Jaynes was denying that people had experiential phenomenal consciousness based on a claim about inflated self-consciousness.

Damasio also denies phenomenal consciousness because of the demand of a sophisticated self-consciousness. You may have noticed an exciting report a few years ago of a patient in a persistent vegetative state (defined behaviorally) studied by the neuroscientists Adrian Owen and Steven Laureys. On some trials, the two instructed the patient to imagine standing still on a tennis court swinging at a ball, and on others to visualize walking from room to room in her home. The patient, they found, showed the same imagistic brain activations (motor areas for tennis, spatial areas for exploring the house) as normally conscious people who were used as controls.

Ned Block is the Silver professor of philosophy, psychology and neural science at New York University.

Well: Narcissism No Longer a Psychiatric Disorder

Posted: 29 Nov 2010 12:26 PM PST

Well: Bike Injuires vs. Running Injuries

Posted: 29 Nov 2010 12:03 PM PST

Well: Asthma Symptoms? Try Caffeine

Posted: 29 Nov 2010 11:44 AM PST

Well: Pumpkin for Breakfast, Dinner and Dessert

Posted: 26 Nov 2010 03:20 PM PST

Well: The Small Print of Medical Credit Cards

Posted: 26 Nov 2010 08:40 AM PST

Personal Health: Head Out for a Daily Dose of Green Space

Posted: 29 Nov 2010 12:30 PM PST

First, the bad news: Americans are suffering from an acute case of “outdoor deprivation disorder,” and the effects on physical and mental health are rising fast. Children aged 8 to 18 today spend more time than ever using electronic media indoors — seven and a half hours a day, according to the Kaiser Family Foundation — and less time in outdoor unstructured activity. In response to the No Child Left Behind law, 30 percent of kindergarten classrooms have eliminated recess to make more room for academics.

The resulting lack of physical activity and a growing disconnect with the natural environment have been linked in a host of studies to obesity and obesity-related diseases in children and adults, including Type 2 diabetes, high blood pressure, heart disease, asthma and nonalcoholic fatty liver disease, as well as vitamin D deficiency, osteoporosis, stress, depression, attention deficit disorder and myopia. Dr. Daphne Miller, a family physician affiliated with the University of California, San Francisco, calls them “diseases of indoor living.”

Now, the good news: There’s a simple remedy — get outside and start moving around in green spaces near and far, most of which are free. A consortium of physicians, health insurers, naturalists and government agencies have banded together to help more people of all ages and economic strata engage in health-enhancing physical activity in parks and other natural environments.

This grass-roots movement has already reached the White House. This year President Obama started the America’s Great Outdoors Initiative, proclaiming June “Great Outdoors Month.” The initiative aims not just to counter sedentary lifestyles but also to reacquaint Americans with the farms, ranches, rivers, forests, national and local parks, fishing holes and beaches that provide opportunities for people “to stay active and healthy.”

The goals dovetail with Michelle Obama’s battle against childhood obesity and her initiative Let’s Move Outside, a program that’s part of her Let’s Move campaign. Dr. Miller said that the aim was to “turn our public lands into public health resources. Doctors around the country are beginning to realize that getting patients out of doors has benefits even beyond getting people to exercise.

“It’s a lot cheaper to go outside and move than it is to build gyms and a lot of hospitals,” she said.

Doctor’s Orders: Be Active

Accordingly, Dr. Miller and a growing number of like-minded doctors have begun writing specific prescriptions for outdoor activity, providing patients with maps, guidelines and programs of gradually increased activity based on their abilities. She said that such prescriptions are necessary because many people “are unfamiliar with the outdoors — they’re scared to walk through a park, and they don’t know what to do when they get there.”

Among possible sources of help: volunteer health guides in parks who can tell people where to go and what to do and park rangers who are trained to advise people who may have health issues. “Our parks provide a huge opportunity,” Dr. Miller said. “Currently, fewer than 40 percent of visitors use them for any form of exercise.”

Some health insurers have come on board as well. SeeChange Health in California and the Blue Cross and Blue Shield Foundation in North Carolina are supporting outdoor programs in their areas, like the Kids in Parks Initiative of the Blue Ridge Parkway Foundation. SeeChange Health this year announced a pilot project to reimburse members for visits to California state parks.

Other movers and shakers include the National Wildlife Federation, which established the “Be Out There” public-education campaign to foster a daily “green hour” during which every child could enjoy 60 minutes of unstructured play and interaction with the natural world. On its Web site, www.nwf.org, the federation has posted the rationale and specific suggestions for schools and families to counter the physical, emotional and educational drain of an “indoor childhood.”

The campaign’s mission “is to return to the nation’s children what they don’t even know they’ve lost: their connection to the natural world,” with activities suitable for all children, whether rural, suburban or urban.

As for its health and educational benefits, the federation cites scientific findings that outdoor play enhances fitness, raises blood levels of vitamin D (which in turn protects against bone loss, heart disease, diabetes and other health problems), improves distance vision, lowers the risk of nearsightedness, reduces symptoms of stress and attention deficit hyperactivity disorder, raises scores on standardized tests and improves students’ critical-thinking skills.

The National Environmental Education Foundation is now training pediatric health care providers to serve as nature champions in their communities.

One study of children living in poor urban environments found that those who relocated to greener (though not more affluent) home surroundings “tended to have the highest levels of cognitive functioning following the move.” The author of the study, Nancy M. Wells, also found in research among rural children that nearby nature can act as a buffer against stressful life events and improve children’s psychological well-being.

Lest you remain unconvinced, I urge you to read the best-selling book “The Last Child in the Woods,” by Richard Louv, who coined the phrase “nature-deficit disorder.” Mr. Louv describes dozens of studies demonstrating the benefits that wilderness outings can have on mental and physical health.

‘Park Prescriptions’

The National Park Service, too, has joined the “park prescriptions” campaign, offering free wellness services that are accessible to all, regardless of health status. (I was shocked to learn on a recent visit to Grand Canyon National Park that, despite many well-maintained trails, only 5 percent of visitors ever venture below the rim of the canyon; about half the people I encountered on the trails were from other countries.)

The park service helped Dr. Eleanor Kennedy, a cardiologist in Little Rock, Ark., create a downtown “Medical Mile,” a section of the Arkansas River Trail, and now hopes to support access to similar open spaces in communities nationwide. Dr. Kennedy reports that once she gets her patients outdoors “they are more likely to be consistent about exercise.” The Medical Mile project, which had an initial goal of $350,000, managed to raise $2.1 million in two years.

Dr. Robert Lambert, a cardiologist at the Heart Clinic of Arkansas, said: “We see too many patients who need our assistance because of their lifestyle, not because of factors beyond their control. That is why my colleagues and I decided to become involved.”

Other programs include Prescription Trails, established in Santa Fe, N.M., with the help of the Centers for Disease Control and Prevention, to counter runaway rates of diabetes in the community. Local physicians get trail guides to distribute to their patients. The Web site www.prescriptiontrailsnm.org is a guide to some of the state’s best park and trail walking and wheelchair rolling paths.

This is the second of two columns on health-promoting physical activity.

This posting includes an audio/video/photo media file: Download Now

Really?: The Claim: A Cup of Coffee can Ease the Symptoms of Asthma

Posted: 29 Nov 2010 12:06 PM PST

THE FACTS Caffeine is known more as a pick-me-up than a home remedy, but for years scientists have wondered whether it may have benefits for people with asthma.

Christoph Niemann

Well

Share your thoughts on this column at the Well blog.

Go to Well »

Related

The suspicion stems in part from its chemical structure, which resembles that of theophylline, a common asthma medication that relaxes the airway muscles and relieves wheezing, shortness of breath and other respiratory problems. Indeed, when caffeine is ingested and broken down by the liver, one byproduct is small amounts of theophylline.

In a 2007 study in the Cochrane Database of Systematic Reviews, researchers pooled and analyzed the results of a half dozen clinical trials looking at the effects of caffeine on asthmatics. They found that caffeine produced small improvements in airway function for up to four hours, compared with a placebo, and that even a small dose — less than the amount in a cup of Starbucks coffee — could improve lung function for up to two hours.

In other words, in a pinch, a cup of coffee or strong tea might provide some momentary relief.

But the improvements are very slight, studies show — certainly not enough to make caffeine a replacement for medication. The other problem is that because of their chemical similarities, consuming too much caffeine can compound any side effects of theophylline. As a result, doctors advise people taking that medication to watch their consumption of coffee, tea, chocolate and other foods with caffeine.

THE BOTTOM LINE Caffeine’s benefits for asthma are real but minimal.


The New Old Age: A War on Dementia

Posted: 26 Nov 2010 08:42 AM PST

Prescriptions: Steep Rise in H.M.O. Costs

Posted: 29 Nov 2010 12:32 PM PST

Prescriptions: This Week's Health Industry News

Posted: 29 Nov 2010 06:49 AM PST

Recipes for Health: Pumpkin and Ginger Scones

Posted: 25 Nov 2010 11:50 PM PST

Just in case you didn’t get enough pumpkin pie flavor at the Thanksgiving table, here’s a nice breakfast pastry for the day after.

Recipes for Health

Martha Rose Shulman presents food that is vibrant and light, full of nutrients but by no means ascetic, fun to cook and to eat.

3/4 cup whole-wheat flour

1 cup all purpose flour

1/2 teaspoon salt

1/4 teaspoon ground ginger

2 teaspoons baking powder

1/2 teaspoon baking soda

4 tablespoons cold unsalted butter, cut into 1/2-inch pieces

1/2 cup pumpkin purée, well drained, canned or made from 1/2 pound fresh

1/4 cup buttermilk

2 tablespoons maple syrup

1/2 cup chopped candied ginger

1. Preheat the oven to 400 degrees. Line a baking sheet with parchment. Sift together the flours, salt, ginger, baking powder and baking soda. Place in the bowl of a food processor fitted with the steel blade.

2. Add the butter to the food processor, and pulse several times until it is distributed throughout the flour. The mixture should have the consistency of coarse cornmeal.

3. Beat together the pumpkin purée, buttermilk and maple syrup in a small bowl, and scrape into the food processor. Add the ginger, and process just until the dough comes together.

4. Scrape onto a lightly floured surface, and gently shape into a rectangle about 3/4 inch thick. Cut into six squares, then cut the squares in half on the diagonal to form 12 triangular pieces. Place on the baking sheet. Bake 12 to 15 minutes until lightly browned. Cool on a rack.

To roast the pumpkin: Preheat the oven to 425 degrees. Cover a baking sheet with foil. Place the pumpkin pieces on the baking sheet, drizzle 2 teaspoons of olive or canola oil on top, cover tightly with foil and place in the oven. Roast for 1 1/2 hours or until thoroughly tender. Remove from the heat, transfer to a strainer or a colander set over a bowl or in the sink, and allow to cool and drain. Peel the pieces, and purée in a food processor fitted with the steel blade.

Yield: 12 scones.

Advance preparation: These will keep for a couple of days well wrapped or in a cookie tin.

Nutritional information per serving: 143 calories; 4 grams fat; 3 grams saturated fat; 10 milligrams cholesterol; 25 grams carbohydrates; 2 grams dietary fiber; 223 milligrams sodium; 3 grams protein

Martha Rose Shulman can be reached at martha-rose-shulman.com. Her latest book is "The Very Best of Recipes for Health."

Study Finds No Progress in Safety at Hospitals

Posted: 25 Nov 2010 01:14 PM PST

Efforts to make hospitals safer for patients are falling short, researchers report in the first large study in a decade to analyze harm from medical care and to track it over time.

The study, conducted from 2002 to 2007 in 10 North Carolina hospitals, found that harm to patients was common and that the number of incidents did not decrease over time. The most common problems were complications from procedures or drugs and hospital-acquired infections.

“It is unlikely that other regions of the country have fared better,” said Dr. Christopher P. Landrigan, the lead author of the study and an assistant professor at Harvard Medical School. The study is being published on Thursday in The New England Journal of Medicine.

It is one of the most rigorous efforts to collect data about patient safety since a landmark report in 1999 found that medical mistakes caused as many as 98,000 deaths and more than one million injuries a year in the United States. That report, by the Institute of Medicine, an independent group that advises the government on health matters, led to a national movement to reduce errors and make hospital stays less hazardous to patients’ health.

Among the preventable problems that Dr. Landrigan’s team identified were severe bleeding during an operation, serious breathing trouble caused by a procedure that was performed incorrectly, a fall that dislocated a patient’s hip and damaged a nerve, and vaginal cuts caused by a vacuum device used to help deliver a baby.

Dr. Landrigan’s team focused on North Carolina because its hospitals, compared with those in most states, have been more involved in programs to improve patient safety.

But instead of improvements, the researchers found a high rate of problems. About 18 percent of patients were harmed by medical care, some more than once, and 63.1 percent of the injuries were judged to be preventable. Most of the problems were temporary and treatable, but some were serious, and a few — 2.4 percent — caused or contributed to a patient’s death, the study found.

The findings were a disappointment but not a surprise, Dr. Landrigan said. Many of the problems were caused by the hospitals’ failure to use measures that had been proved to avert mistakes and to prevent infections from devices like urinary catheters, ventilators and lines inserted into veins and arteries.

“Until there is a more coordinated effort to implement those strategies proven beneficial, I think that progress in patient safety will be very slow,” he said.

An expert on hospital safety who was not associated with the study said the findings were a warning for the patient-safety movement. “We need to do more, and to do it more quickly,” said the expert, Dr. Robert M. Wachter, the chief of hospital medicine at the University of California, San Francisco.

A recent government report found similar results, saying that in October 2008, 13.5 percent of Medicare beneficiaries — 134,000 patients — experienced “adverse events” during hospital stays. The report said the extra treatment required as a result of the injuries could cost Medicare several billion dollars a year. And in 1.5 percent of the patients — 15,000 in the month studied — medical mistakes contributed to their deaths. That report, issued this month by the inspector general of the Department of Health and Human Services, was based on a sample of Medicare records from patients discharged from hospitals.

Dr. Landrigan’s study reviewed the records of 2,341 patients admitted to 10 hospitals — in both urban and rural areas and involving large and small medical centers. (The hospitals were not named.) The researchers used a “trigger tool,” a list of 54 red flags that indicated something could have gone wrong. They included drugs used only to reverse an overdose, the presence of bedsores or the patient’s readmission to the hospital within 30 days.

The researchers found 588 instances in which a patient was harmed by medical care, or 25.1 injuries per 100 admissions.

Not all the problems were serious. Most were temporary and treatable, like a bout with severe low blood sugar from receiving too much insulin or a urinary infection caused by a catheter. But 42.7 percent of them required extra time in the hospital for treatment of problems like an infected surgical incision.

In 2.9 percent of the cases, patients suffered a permanent injury — brain damage from a stroke that could have been prevented after an operation, for example. A little more than 8 percent of the problems were life-threatening, like severe bleeding during surgery. And 2.4 percent of them caused or contributed to a patient’s death — like bleeding and organ failure after surgery.

Medication errors caused problems in 162 cases. Computerized systems for ordering drugs can cut such mistakes by up to 80 percent, Dr. Landrigan said. But only 17 percent of hospitals have such systems.

For the most part, the reporting of medical errors or harm to patients is voluntary, and that “vastly underestimates the frequency of errors and injuries that occur,” Dr. Landrigan said.

“We need a monitoring system that is mandatory,” he said. “There has to be some mechanism for federal-level reporting, where hospitals across the country are held to it.”

Dr. Mark R. Chassin, president of the Joint Commission, which accredits hospitals, cautioned that the study was limited by its list of “triggers.” If a hospital had performed a completely unnecessary operation, but had done it well, the study would not have uncovered it, he said. Similarly, he said, the study would not have found areas where many hospitals have made progress, such as in making sure that patients who had heart attacks or heart failure were sent home with the right medicines.

The bottom line, he said, “is that preventable complications are way too frequent in American health care, and “it’s not a problem we’re going to get rid of in six months or a year.”

Dr. Wachter said the study made clear the difficulty in improving patients’ safety.

“Process changes, like a new computer system or the use of a checklist, may help a bit,” he said, “but if they are not embedded in a system in which the providers are engaged in safety efforts, educated about how to identify safety hazards and fix them, and have a culture of strong communication and teamwork, progress may be painfully slow.”

Leah Binder, the chief executive officer of the Leapfrog Group, a patient safety organization whose members include large employers trying to improve health care, said it was essential that hospitals be more open about reporting problems.

“What we know works in a general sense is a competitive open market where consumers can compare providers and services,” she said. “Right now you ought to be able to know the infection rate of every hospital in your community.”

For hospitals with poor scores, there should be consequences, Ms. Binder said: “And the consequences need to be the feet of the American public.”

This posting includes an audio/video/photo media file: Download Now

U.S. Orders Vast Review of Bioethics

Posted: 24 Nov 2010 07:12 PM PST

WASHINGTON (AP) — President Obama on Wednesday ordered a vast review to ensure the ethical treatment of people who take part in research backed by the federal government.

His action is a response to the revelation this year that American scientists intentionally infected people at a Guatemalan mental hospital with syphilis in the 1940s.

In a memorandum released by the White House, Mr. Obama announced a review of federal and international standards to guard the health and well-being of research participants, known as human subjects. He also ordered a fresh inquiry into what happened in the widely condemned experiment in Guatemala.

In that case, American scientists deliberately infected prisoners and patients in a mental hospital with syphilis from 1946 to 1948. It was apparently an effort to test if penicillin, then relatively new, could prevent some sexually transmitted infections. Secretary of State Hillary Rodham Clinton said in October that it was “reprehensible research,” and both she and Mr. Obama called Guatemala’s president, Álvaro Colom, to apologize.

“While I believe the research community has made tremendous progress in the area of human subjects protection, what took place in Guatemala is a sobering reminder of past abuses,” Mr. Obama said in the memo to Amy Gutmann, the chairwoman of the Presidential Commission for the Study of Bioethical Issues.

Mr. Obama said the commission must use its expertise across the fields of science, policy, ethics and religion to protect those who take part in medical research. The president added, “We owe it to the people of Guatemala and future generations of volunteers.”

Mr. Obama ordered Dr. Gutmann to form a panel, starting in January, to begin the reviews and to provide him with a report and recommendations within nine months. He said the members must get input from experts in Guatemala and around the world.

Enter your email address:

Delivered by FeedBurner